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ABSTRACT 
 
 
 
 
Introduction: While a large amount of data about the epidemiology of asthma, 
allergy, COPD, chronic bronchitis and respiratory symptoms are available from 
developed countries, the information about these diseases and conditions in 
developing countries in south-east Asia are scarce. There are, however, several 
reports indicating an increase in asthma and allergy parallel to urbanization in 
developing countries. The proportion of smoking men in south-east Asia including 
Vietnam is large. 
 
Aim: The aim of this thesis was to assess the prevalence of obstructive airway 
diseases and symptoms and their relation with demographic data including smoking 
habits among adults in rural and urban Vietnam. Special interest was paid to asthma, 
rhinitis, allergic sensitization and COPD.  
 
Methods: The study was conducted in two parts. A random sample of subjects aged 
21 -70 years were invited; 3008 subjects living in an inner city area of Hanoi, 
Hoankiem, and 4000 in a rural area of Bavi in northern Vietnam. An internationally 
used questionnaire was delivered by field workers to the study subjects. From the 
questionnaire responders, a randomly selected sample of 750 subjects from each of 
the two areas was invited to the second part of the study. The second part consisted of 
clinical examinations including structured interview, dynamic spirometry, skin prick 
testing (SPT) and bronchial provocation testing with methacholine. The SPT panel 
included ten common indoor and outdoor allergens. For the structured interview a 
modified GA
2
LEN study questionnaire was used. The spirometry followed the 
American Thoracic Society guidelines and East Asian reference values were used. 
COPD was defined by using the fixed ratio of FEV1/FVC < 0.7.  
 
Results: The response rate to the questionnaire was 92% in Bavi and 70% in 
Hoankiem. Of men in Bavi 67.8% (Hoankiem 49.7%; p < 0.001) were smokers, while 
of women 4.2% were smokers in Hoankiem (Bavi 1.2%; p < 0.001). The prevalence 
of ever having had asthma was in Hoankiem 5.6% (Bavi 3.9%; p = 0.003) with no 
major gender difference. The most common symptom was longstanding cough 
(Hoankiem 18.1%, Bavi 12.0%; p < 0.001) followed by sputum production, while the 
prevalence of symptoms common in asthma was considerably lower. Respiratory 
symptoms were slightly more common in men than women. Allergic rhinitis ever or 
chronic nasal symptoms were reported by 50.2%. The prevalence of allergic rhinitis 
was considerably higher in the urban area compared to the rural, 29.6% vs. 10.0% 
(p<0.001). Allergic rhinitis ever and chronic nasal symptoms were both significantly 
associated with asthma and respiratory symptoms (p<0.001). Exposure to gas, dust or 
fumes at work was significantly associated with all rhinitis conditions. No major 
gender differences were found, and smoking was not significantly associated with the 
nasal conditions.  
The participation rate in the clinical part was 46%. The representativeness of the 
participants was good as no statistical difference in prevalence of symptoms was 
found between the participants and all responders in the questionnaire survey.  Of 
men 36.9% and of women 31.0% (n.s.) had positive SPT to at least one allergen. The 
  
most common sensitizer was the storage mite, Blomia tropicalis (men 27.7%; women 
18.7%, p = 0.013). Sensitization to mites and cockroach were common (26.1%; 
13.2%), and was strongly associated with allergic rhinitis. Young age, male sex and 
occupational exposure to gas, dust and fumes were risk factors for allergic 
sensitization to mites or cockroach. A significant positive association between the 
number of positive SPT reactions and airway hyper-reactivity was found. 
The overall prevalence of COPD was 7.1% (men 10.9%; women 3.9%), and the 
prevalence increased considerably by age. The distribution of COPD by disease 
severity was 12.5% severe or very severe COPD (FEV1<50% of predicted), 40% 
moderate COPD (50≤ FEV1 <80% of pred.) and 47.5% mild COPD (FEV1≥80% of 
pred.). Among men with COPD all but one was current or ex-smokers, while the 
women with COPD were all never smokers. Among men, COPD was strongly related 
to the number of pack-years of tobacco consumption and a half of smokers aged ≥60 
years had developed COPD.   
 
Conclusions: The prevalence of asthma in adults may have increased in both urban 
and rural Vietnam, as the few previous estimates have found 2% of adults having 
asthma. The majority of men were smokers versus a few percent of women. A half of 
the studied population had rhinitis conditions with allergic rhinitis being more 
common in the urban area, however, a disparity in the knowledge about what allergy 
is may have contributed to this urban-rural difference. The pattern and prevalence of 
allergic sensitizers conforms to results from other areas with a similar climate. Taking 
into account the young population of Vietnam, the prevalence of COPD must be 
considered as high particularly among smoking men. Except increasing age and a 
previous history of asthma, no other risk factors for COPD among women could be 
demonstrated.  
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INTRODUCTION 
 
 
 
Asthma, allergic rhinitis (AR) and COPD (Chronic Obstructive Pulmonary 
Disease) represent significant health problems throughout the world. These 
diseases cause a significant economic burden on health care systems and the 
society as a whole, and they all affect quality of life. Approximately 300 million 
people worldwide currently have asthma, and its prevalence increases by 50% 
every decade particularly in developing countries parallel to urbanization (GINA, 
2010). Allergic disease is the fifth leading chronic disease in the United States 
among all ages (Ebert & Pillsbury, 2011).  By 2020, COPD will be the third 
leading cause of death and the fifth leading cause of disability adjusted life years 
in the world (GOLD, 2010). Asthma, rhinitis and COPD are multi-factorial 
processes and caused by a complex combination of hereditary and environmental 
factors.   
 
Among the data of respiratory and allergic diseases in the world, the information 
from Vietnam is rare, and this is true especially for adults in the northern part of 
the country. With the exception of one abstract from the European Respiratory 
Society´s annual congress in 2010 (Phan et al., 2010), there are actually no 
reference to data of adult asthma, rhinitis or COPD from northern Vietnam 
published in international scientific journals. Data about these diseases based on 
population studies are lacking also in domestic journals. Thus there was a need of 
a well-designed population study to obtain clear information of respiratory and 
allergic diseases among adults in the northern part of Vietnam.   
 
Vietnam is a developing country. From a renovation in 1986, the economy has 
developed quickly. As a consequence, the quality of life of the population is 
increasing, but the development has also side effects in terms of increasing air 
pollution. I myself am a physician working at the Allergy & Clinical Immunology 
Department, Bachmai Hospital, Hanoi. At the hospital, we have frequent contacts 
with asthma and COPD patients. Most of them seek for aid from health care only 
during exacerbations. This creates an impact not only for the health care system 
but also for social life. When I read the papers of the study about asthma and 
COPD in northern Sweden, I got an idea of a similar study in Vietnam. Thru the 
co-operation between Hanoi Medical University and Karolinska Institutet this 
study could be realised. It has been an interesting journey to face possibilities and 
difficulties in performing the study using methods in my country that are used in 
developed countries. Now I am very happy to present the results of my study in 
this book.  
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BACKGROUND 
 
 
 
Vietnam - socio-economic and environmental aspects 
 
Since 1986, Vietnam has been involved in a renovation process (đổi mới) in order 
to promote socio-economic development and closer integration with the rest of the 
world. The market forces freed by the renovation process have produced a very 
strong economic growth in Vietnam during the 1990s. Market principles are now 
accepted as the basis for remunerating labour, for determining land use and also 
for determining public-sector accountability. The household economy is thriving, 
rural production is becoming more diversified and better rewarded, and more and 
better housing is being produced in the cities. Vietnam has opened its economy to 
trade and foreign investments and opened its borders to flows of people: tourists, 
people involved in business, students and scholars. Through trade and diplomacy, 
Vietnam has become increasingly involved in the region, and has successfully 
joined the Association of South East Asian Nations (ASEAN). 
 
 
 
Figure 1. Air pollution on the streets of Hanoi is partly caused by motorbike 
fuel  
 
 
The extremely fast development, growth, and increased energy consumption 
during the last decades has contributed significantly to improve the living 
standard of people in Vietnam. However, the development has put considerable 
pressure on environment, mainly thru air pollution. This pollution is mainly in the 
form of emissions, dust, water, waste and sewage. 
  
The air in Hanoi contains high levels of benzene, sulphur dioxide and microscopic 
dust known as PM-10 (Particulate matter ≤10µg), which is one of the most 
dangerous pollutants. Levels of PM-10 of about 80 micrograms per m
3 
has been 
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measured in Hanoi, which is twice as high compared to the current level in 
Bangkok and well above the guideline of 20 micrograms per m
3
 set by the World 
Health Organization (WHO) (Fuller, 2007). Air pollution can be seen, smelt and 
felt in Hanoi (figure 1). The abundant dirt comes from mainly from vehicles 
including motorbikes and cars, visible garbage, drainage systems, untreated 
sewage and burning of waste, all contribute to poor air quality. Adding to these 
dangers, high humidity and low awareness of proper sanitation has created 
favourable conditions for bacteria to bind with dust, which is one way diseases 
can spread. 
 
Although there have been positive developments regarding the environment, the 
level of the awareness of environmental protection in the general public and even 
in some enterprises needs to improve further. Many local authorities and 
enterprises pay insufficient attention to implement important decisions that have 
been made in order to improve the environment, but instead they are waiting for 
support and subsidies from the central government. 
 
 
 
Asthma, allergic diseases and COPD 
 
Prevalence trends of asthma, allergic diseases and COPD 
 
The Global Initiative for Asthma (GINA) reports adult asthma prevalence ranging 
from 5-18% in the world (GINA, 2010). It is estimated that asthma affects as 
many as 300 million people worldwide, and this is expected to increase to 400 
million by 2025 (GINA, 2010). AR is even more common than asthma with 
estimates of prevalence of 10-20%, and it is expected to affect 500 million people 
worldwide (Ebert & Pillsbury, 2011). AR is the most common allergic disease at 
least in the Western part of the world (Bauchau & Durham, 2004).  
 
The increase in prevalence of asthma in developed countries may have levelled 
off. Two studies performed 10 and 18 years apart in Sweden found that the 
prevalence of asthma had probably not increased, while the prevalence of most 
respiratory symptoms had decreased (Ekerljung et al., 2010a; Lotvall et al., 2009). 
In England, the incidence rate of asthma has decreased particularly in children 
below the age of five years, and a decrease in the lifetime prevalence of asthma 
was also noticed (Simpson & Sheikh, 2010). In Denmark, the prevalence of 
asthma and bronchial hyperactivity among schoolchildren did not change over a 
ten year period (Zilmer et al., 2011). 
 
In contrast to particularly Australia and some European countries, the prevalence 
of asthma and allergic diseases seems to be increasing in several developing 
countries (Asher et al., 2006). In order to determine the time trends of childhood 
asthma in Taiwan, data from two nationwide ISAAC (International Study of 
Asthma and Allergies in Childhood) surveys were compared. The results showed 
a general tendency towards an increase in lifetime prevalence of physician-
diagnosed asthma and asthma symptoms and the increase was more marked 
among girls than boys (Lee et al., 2007). Another study conducted in Morocco 
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using the ISAAC questionnaire also found an increase of allergic symptoms over 
a five-year period (Bouayad et al., 2006).  
 
In Vietnam, the prevalence of asthma or asthma-like symptoms in the southern 
part was 2.4% in ages more than five years in 2004 (Sy et al., 2007). In contrast, a 
study among children and teenagers following the ISAAC protocol in Hanoi, 
Vietnam, found the prevalence of ever wheeze, ever asthma and ever having had 
hay fever to be 24.9%,  12.1%, and 7.8%, respectively (Nga et al., 2003).  
 
The increase in asthma prevalence has raised concerns for the heavy burden of the 
disease on patients and society. Increased urbanisation in the developing world 
may contribute to these trends as a higher prevalence of allergic diseases has been 
observed in urban compared to rural environments (Platts-Mills et al., 2005). The 
'hygiene hypothesis' or the 'microbial exposure hypothesis’ can be used to explain 
the disparities of the prevalence of allergic diseases between developed and 
developing countries. The hypothesis proposes that a cause of the recent rapid rise 
in atopic disorders could be a consequence of a lower incidence of early childhood 
infections. A consensus is probably under development around the view that more 
fundamental changes in lifestyle have led to decreased exposure to certain 
microbial or other species, such as helminthic, that are important for the 
development of immune-regulatory mechanisms (Bloomfield et al., 2006). Factors 
that may contribute to the diversity include lifestyle changes, climate changes, 
increasing indoor and outdoor air pollution (GINA, 2010).  
 
COPD is a common disabling disease. The prevalence and mortality of COPD are 
increasing and COPD has become a serious public health problem worldwide 
(GOLD, 2010). Unfortunately, although COPD is preventable, it is 
underdiagnosed for many reasons (GOLD, 2010). Prevalence estimates of COPD 
differ largely depending on the diagnostic instruments used, study design, and the 
studied populations (GOLD, 2010). In northern Sweden, the prevalence of COPD 
was estimated at 7.6%, 14.0%, and 14.1% according to British Thoracic Society 
(BTS), European Respiratory Society (ERS), and Chronic Obstructive Lung 
Disease (GOLD) criteria, respectively (Lindberg et al., 2005). A study based on 
information about smoking habits in 12 Asia Pacific countries and regions 
indicated that the prevalence of COPD in Vietnam, despite a young population, is 
the highest of the Asia Pacific countries, 6.7% (Tan et al., 2003).  
 
 
The burden of asthma, allergic rhinitis and COPD 
 
The economic burden of asthma, AR and COPD includes the costs on the health 
care system as well as the cost on the society. Direct medical costs include costs 
of health care, such as hospitalisations, doctor’s visits and medications. However, 
the indirect costs such as loose of work days, absence from school, costs 
attributed to disability and premature death are as important as direct medical 
costs. Costs per patient vary across countries because these costs depend on how 
the health care is provided and paid. In USA the total costs for the medical 
expenditures of asthma have been estimated at 18 billion USD annually (Sullivan 
et al., 2011). AR alone was responsible for 3.5 million missed days of work in 
USA and more than $6 billion was spent on prescriptions of medications for AR 
in 2000 (Stempel & Woolf, 2002). In European Union, the total direct costs of 
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respiratory diseases have been estimated at about 6% of the total health care 
budget with COPD accounting for 56% (39 billion Euros) of the costs of 
respiratory diseases (GOLD, 2010). Following a study in Bangkok, Thailand, the 
Thai had to pay 7 000 – 10 000 Bht per day for care at an Intensive Care Unit 
(ICU) for COPD (Saenghirunvattana et al., 2001). In addition to direct and 
indirect costs, respiratory diseases effect quality of life and activities of daily 
living including work (GOLD, 2010).  
 
AR and asthma are often associated, and the two diseases interact at various 
levels. Rhinitis often precedes the development of asthma among adults and can 
contribute to unsatisfactory asthma control (Bousquet et al., 2008). While not life-
threatening, AR has a major impact on quality of life, overall health and daily 
functioning (Seth et al., 2007). Untreated AR has been associated with fatigue, 
irritability and restlessness. Sleep disturbance is a serious complication of AR and 
can reduce ability to concentrate and to learning and may contribute to family 
dysfunction. The importance of treating AR is magnified by the additional 
potential benefit of improving other associated co-morbidities (Bousquet et al., 
2008). 
 
 
 
Allergic sensitization 
 
 
Mechanism of allergic sensitization 
 
In normal conditions, exposure to non-infectious protein antigens induces 
tolerance, which is essential to maintain the normal mucosal homeostasis under 
exposure to environmental antigens.  
 
Allergic sensitization occurs by a failure in the mechanisms of tolerance, leading 
to allergic sensitization and development of an inflammatory reaction. Allergic 
reactions can occur as immediate reactions, late-phase reactions, or as a chronic 
allergic inflammation. Immediate or acute-phase reactions occur within seconds to 
minutes after allergen exposure (Curotto de Lafaille et al., 2010), so called type I 
hypersensitivity. The allergic reaction requires first sensitization to a specific 
allergen, it occurs mostly in genetically predisposed individuals, and the reaction 
is mediated by IgE antibodies. This class of antibodies binds with a high affinity 
to Fc-receptors on the surface of the tissue of mast cells and blood basophils. Mast 
cells and basophils that are coated with IgE are said to be sensitized. Re-exposure 
to the antigen can then create a cross-linking with these IgE antibodies resulting in 
release and formation of chemical mediators from the sensitized cells (figure 2). 
 
 
Allergens and skin prick testing 
 
An allergen is another word for an antigen that causes an allergic reaction. The 
most important allergens for respiratory diseases are those that are inhaled. 
Common inhaled allergens include animal dander (skin, saliva), dust mites, 
cockroach particles, moulds, and pollen. The pattern of different allergens on 
allergic sensitization and morbidity varies between countries. In so called 
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developed countries, the most common allergens include animal dander like cat 
and dog, and pollens (Pallasaho et al., 2006; E. Ronmark et al., 2009a). A recent 
nationwide survey reported that 55% of the people in the United States were 
tested positive to an allergic response to one or more allergens (AAAAI, 2009). In 
Sweden, the prevalence of any positive SPT response was highest, 55%, in 
subjects aged 20 to 29 years and low, 26%, in subjects aged 50 to 60 years (Warm 
et al., 2011). In contrast, in developing countries, house dust mite, storage mite 
and cockroach are often the main sensitizers (Baratawidjaja et al., 1999; Puccio et 
al., 2004). The most common known sensitizers in Vietnam are mites and 
cockroach (Sy et al., 2007), results similar to results from other studies in south 
east Asia (Chew et al., 1999; Prasarnphanich & Sindhurat, 2005). Asthma and AR 
are known to be associated with atopy documented with measures of serum IgE or 
by skin prick testing (E. Ronmark et al., 2009a).  
 
 
 
Figure 2. Type I hypersensitivity (W. Zhang, 2007) 
 
 
For assessing the presence of allergen-specific IgE antibodies, skin prick testing is 
preferred over blood allergy tests because generally it is more sensitive, simpler to 
use, less expensive, and was at least previously regarded as more specific 
(Dreborg et al., 1989). Some patients may believe they have determined their own 
allergic sensitization by observation, but a skin test has been shown to be better 
than patient observation to detect allergy.  
 
Skin prick testing may not be an option if the subject has a widespread skin 
disease or has taken antihistamines less than 72 hours before a planned testing. If 
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a patient has had a serious life threatening anaphylactic reaction, some 
allergologists prefer an initial blood test prior to performing a skin prick test. 
 
 
 
Airway hyper responsiveness 
 
Airway hyper responsiveness, AHR (or bronchial hyper-reactivity, BHR) refers to 
a condition in which the airways react with an exaggerated broncho-constriction 
response to stimuli ( Hargreave, et al., 1986).  
 
 
Figure 3. Factors affecting the variable and persistent components of AHR 
(Busse, 2010) 
 
 
The airways of asthmatics respond with a greater constriction to a certain stimulus 
than the airways of healthy subjects. It is a characteristic feature of asthma and 
can be demonstrated in almost all patients with a clinically relevant asthma 
(Busse, 2010). Further, AHR occurs often prior to the development of the 
symptomatic diseases. However, there is a considerable variability in the intensity 
of AHR in patients with asthma, and the level of AHR varies also within 
individuals with asthma. In addition, inter-current provokers, such as viral-
induced exacerbations, allergen exposure, and occupational exposures, can 
temporarily enhance the underlying AHR in individual patients (figure 3). 
Furthermore, treatment of asthma not only can improve airflow limitation and 
reduce symptoms but can also considerably modify the underlying AHR 
(Brannan, 2010). Whether AHR is a factor of importance for the development of 
COPD is under debate.    
 
There are several methods used to measure AHR. Methacholine test is a direct test 
that has high a sensitivity, is cheap and is easy to perform (Cockcroft, 2010). The 
prevalence of AHR in different populations may vary considerably and is 
probably to a great extend a result of different methods of measure and different 
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definitions of AHR. An epidemiological study in Finland found the prevalence of 
AHR to be about 20% using both methacholine and histamine (Juusela et al., 
2008). In Sweden, when using another method, the prevalence of AHR was 11% 
in men and 15% in women (Norrman et al., 1998). Following a nationwide cross 
sectional survey among adults aged 20 to 44 years in Thailand, the prevalence of 
AHR was only 3% (Dejsomritrutai et al., 2006).  The prevalence of AHR in 
students aged 11-17 years in Guangzhou, China was estimated at 4% (N. S. Zhong 
et al., 1990).   
 
 
 
Major risk factors for asthma, allergic diseases and COPD 
 
In this chapter, mainly genetic factors, air pollution including occupational and 
other environmental exposures, tobacco smoke, and socio-economic status will be 
discussed. Other factors that influence the risk of asthma, allergic diseases and 
COPD, such as infections, diet, life style factors will not be discussed in more 
detail. 
 
 
Genetic factors 
 
Asthma and AR are results of the complex interaction between genes and 
environment. The strongest risk factor for the development of asthma and AR is a 
family history of asthma or atopy among primary relatives (Bjerg et al., 2007). If 
one parent is allergic the risk of allergy in the offspring is 50%, and if both parent 
are allergic this risk increases to 75% (Franzese & Burkhalter, 2010). If one parent 
has asthma, the risk for the child to develop  asthma is three folds higher 
compared to children without parental asthma, while this risk is ten times higher if 
both parents have asthma (Bjerg et al., 2007). Family and twin studies strongly 
indicate that genetics play an importance role in the development of asthma and 
allergy (van Beijsterveldt & Boomsma, 2007). The risks of developing hay fever, 
eczema and specific IgE are higher for monozygotic than for dizygotic twins 
(Strachan et al., 2001), and genetic factors play an important role in the 
development of these diseases. There are consistently replicated regions on the 
long arms of chromosomes 2, 5, 6, 12 and 13, and more than 100 gens are 
associated with allergy or asthma in different populations (Ober & Hoffjan, 2006). 
Genetic studies of intermediate phenotypes may facilitate the discovery of 
susceptibility genes for asthma or allergic diseases, or they may only identify 
genes that influence normal variation in the trait itself (Ober & Yao, 2011).  
 
The best known genetic factor linked to COPD is a deficiency of the serine 
protease α1-antitrypsin, which varies in 1–3% of patients with COPD (Stoller & 
Aboussouan, 2005). Alpha-1 antitrypsin is a naturally occurring enzyme that 
protects the lungs from damage. Having low concentrations of this enzyme, 
particularly in combination with smoking or other exposures, increases the risk of 
particularly panlobular emphysema (GOLD, 2010). Smoking has been clearly 
identified as the primary cause for COPD, and up to 50% of smokers develop 
COPD sooner or later (Lundback et al., 2003; Vozoris & Stanbrook, 2011). 
However, not all smokers develop clinically relevant COPD, which suggest that 
genetic factors may modify each individual’s risk (GOLD, 2010).  
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Air pollution 
 
Importance pollutants that have contributed to the increase in allergic diseases, 
particularly asthma, include ozone, nitrogen dioxide (NO2) and diesel exhaust 
particles (DEPs) (Parnia et al., 2002). Ozone causes increasing permeability of the 
airways to proteins allowing allergenic particles and proteins to penetrate deeper 
into the mucosa of the airways, and either increase or alter the immune response 
to the allergens (Kelly & Fussell, 2011). NO2 may act by decreasing the threshold 
of sensitization to allergen exposure as well as by increasing the likelihood of 
respiratory virus infections in the airway, and may thus cause lower airway 
symptoms (Kelly & Fussell, 2011). DEPs may act as a carriers for the transport of 
allergens into the airways by adsorbing allergenic proteins onto their surface 
(Knox et al., 1997), and thus act as an adjuvants in promoting the switching of B-
cells to produce allergen-specific IgE (Takenaka et al., 1995) and affect a number 
of downstream immunological mechanisms leading to increased prevalence or 
increased severity of allergic and asthmatic disorders (Terada et al., 1999). 
 
 
 
 
Figure 4. The common way of cooking in rural area in northern Vietnam 
 
 
Many studies have shown a substantial association between elevated levels of 
particular pollutants and an increase in allergic conditions (H. Kim & Bernstein, 
2009; Lindgren et al., 2009). Exposure from air pollutants inside the homes, 
particularly in developing countries, is a risk factor for asthma, allergic diseases, 
and COPD due to exposure from smoke when cooking or from heating when 
using open fires in poorly ventilated houses. This risk is of importance especially 
in women (Idolor et al., 2011).  
 
The most important risk factor for development of COPD among non-smokers in 
developing countries might be exposure to biomass fuels, such as coal, straw, 
animal dung, crop residues, and wood, which are used for heating and cooking in 
poorly ventilated homes (figure 4) (GOLD, 2010). In China, the prevalence of 
COPD in non-smoking women was three times higher in rural areas, where almost 
all households used biomass fuel for cooking and heating, compared to urban 
areas where this way of cooking and heating of houses was common (S. Liu et al., 
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2007). Globally, WHO estimates that in low and middle level income countries, 
35% of subjects with COPD have developed COPD after exposure to indoor 
smoke from biomass fuels. Furthermore, WHO suggests that 36% of mortality 
from lower respiratory disease is also related to indoor smoke exposure (Mannino 
& Buist, 2007). A report from the Philippines showed the prevalence of COPD 
was three to four times higher in subjects who had used firewood for cooking for 
more than 60 years (Idolor et al., 2011).    
 
According to several studies among both adults and children, including two 
studies in Sweden, living close to high traffic flows increased the asthma 
incidence in adults (Lindgren et al., 2009). As referred previously, several studies 
have shown that diesel exhaust particles can induce the development of the 
allergic immune response and enhance allergic inflammation (Polosa et al., 2002). 
Certain gaseous components of the atmosphere which contribute to keep the Earth 
warm are called greenhouse gases. Anthropogenic emissions of greenhouse gases, 
which include carbon dioxide and methane, contribute to this process. The effects 
of these changes vary by region with implications for many ecosystems as well as 
for human health. Many studies have indicated that the pollen season, typically 
indicated by regionally specific tree pollens, is longer and the annual pollen 
production is increasing (Sheffield et al., 2011).  
 
Exposure to air pollution at work place is significantly associated with allergic 
diseases and COPD (Hedlund et al., 2008). Asthma is the most common 
occupational respiratory disorder in most industrialized countries (Hedlund et al., 
2008; Kogevinas et al., 2007). These exposures include organic and inorganic 
dusts, chemical agents, dust and fumes. The most important way of preventing 
occupational respiratory diseases is elimination or reduction of exposure to 
occupational exposures including sensitizers.  
 
 
Tobacco smoke 
 
Cigarette smoking leads to changes in the cells causing swelling and inflammation 
in the airways and lungs gradually leading to a loss of lung function. These 
damaging changes cannot be reversed, although quitting smoking reduces 
inflammation, why quitting smoking in early stages of diseases such as asthma or 
COPD helps to stay healthier than a continuation of smoking (figure 5) (Fletcher 
& Peto, 1977).  
 
Exposure to tobacco smoke increases the risk of developing respiratory symptoms 
such as wheezing, and infants exposed to second hand smoke have up to a four-
fold increase in airway hyper-responsiveness to histamine challenge 
(Nimmagadda & Evans, 1999). In addition, smoking exposure has been shown to 
increase the number of emergency department visits due to asthma compared to 
patients not exposed to second hand smoke (Nimmagadda & Evans, 1999). Active 
smoking during pregnancy will alter the fetal lung development and contribute to 
the development of asthma in children. In addition, a consequence of passive 
smoking is lateness in lung development of the fetus (Karmaus et al., 2008). 
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Figure 5. Lung function by age and smoking habits (Fletcher & Peto, 1977) 
 
 
Whereas in the early 1960s, one out of two adults smoked in the Western world, 
today fewer than one out of five adults are daily smokers in most industrialised 
countries (WHO, 2009). Every minute, more than 12 million cigarettes are being 
smoked throughout the world (WHO, 2009). The tobacco epidemic has moved 
from the West to the East. In 2010, 28% of adults in China, 53% of men and 2% 
of women, were estimated to be current smokers (Li et al., 2011). Following a 
study conducted in the two biggest cities of Vietnam and other cities in several 
countries, Vietnamese men had the highest smoking prevalence (Jenkins et al., 
1997). 
 
 
 
Gender and age distribution of asthma, COPD and allergic diseases 
 
Among children, the prevalence of asthma in boys is higher than in girls (Bjerg et 
al., 2007). In contrast to children, women are more likely to have asthma and 
other allergic diseases than men (Kynyk et al., 2011), however, there are some 
results that are conflicting. In addition, women had more asthma control problems 
and lower asthma related quality of live compared with men (Temprano & 
Mannino, 2009). Furthermore, asthma triggers have also been more frequently 
found in women (Kynyk et al., 2011). Peri-menopausal and post-menopausal 
women have an increased prevalence of asthma, allergic rhinitis, and wheeze 
(Jensen-Jarolim & Untersmayr, 2008). These gender-related differences might be 
caused by hypersensitivity to their own sex hormones or by other hormonal 
processes (Jensen-Jarolim & Untersmayr, 2008).   
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In opposite to allergic diseases, COPD is generally more common among men 
than women (GOLD, 2010). However, over the past decades the prevalence of 
COPD is increasing especially among women in developed countries. This 
increase probably reflects changing patterns of smoking habits among men and 
women (GOLD, 2010). The increase of COPD in women is parallel with the raise 
in smoking among women. Above that, women are more susceptible to the effect 
of smoking than men (GOLD, 2010).   
 
Respiratory and allergic diseases vary by age with asthma symptoms peaking in 
childhood and adolescence (Nathan et al., 2008). Allergic sensitization is also 
more common among young subjects compared to older (Raukas-Kivioja et al., 
2003; Warm et al., 2011). On the other hand, the prevalence of COPD increases 
with age (Kotaniemi et al., 2005; Lundback et al., 2003). There is a physiological 
decline in respiratory function by age which begins around the age of 30 to 40 
years (Raherison & Girodet, 2009). The life expectancy is increasing all over the 
world, so this thus can contribute to the increasing prevalence of COPD 
worldwide.  
 
 
Socio-economic status 
 
The relation between socio-economic status (SES) and asthma in adults is not well 
understood. Studies have shown increased asthma hospital admissions among 
those who are materially deprived and increased asthma severity in low socio-
economic classes (Farfel et al., 2010). However, the association between SES and 
asthma prevalence is less clear. The hygiene hypothesis implies that asthma is 
more prevalent in higher socio-economic classes (Bloomfield et al., 2006). High 
socio-economic status was still associated with a relatively high prevalence of 
asthma according to some studies, for instance a recent study among adolescents 
in Israel (Farfel et al., 2010). However, in a meta-analysis study, the authors 
concluded that community influences of living in low-educational areas are 
associated with asthma, independently of the subjects' own educational level and 
social class (Basagana et al., 2004). Also recent studies in developed countries, 
such as Sweden, have found asthma and symptoms of asthma to be more common 
in low socio-economic classes both in children and adults (Almqvist et al., 2005; 
Ekerljung et al., 2010b), and also the incidence of asthma was higher in low socio-
economic classes in these studies.   
 
Populations living in poor social and economic conditions are at a higher risk of 
developing COPD even after effects of smoking been taken into account (GOLD, 
2010). In USA, low SES is a risk factor for several adverse health outcomes of 
COPD (Eisner et al., 2011). SES is a risk factor for COPD also in China 
independently of current or passive smoking (Yin et al., 2011). However, SES 
probably covers various risk factors, such as diet, infections and occupational 
exposures and other environmental factors including passive smoking. Since 
several of these factors exist from childhood, they may have an impact on adult 
lung function.  
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AIMS 
 
 
 
1. To study the prevalence of respiratory symptoms, asthma and chronic 
bronchitis, and to explore the association between these respiratory diseases 
and conditions with demographic data including smoking habits among adults 
in rural and urban northern Vietnam. 
 
 
2. To assess the prevalence and risk factors for allergic rhinitis, chronic nasal 
blocking and chronic runny nose, and to explore the association between the 
rhinitis conditions and other respiratory symptoms and diseases. 
 
 
3. To investigate the prevalence of allergic sensitization in rural and urban 
northern Vietnam, it’s determinants and the relation with asthma and rhinitis.  
 
 
4. To study the prevalence of COPD including the prevalence by disease severity 
and risk factors for COPD in rural and urban northern Vietnam. 
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MATERIAL AND METHOD 
 
 
 
The studies were based on a cross-sectional survey and were performed in two 
steps. Part one was a questionnaire survey conducted from September 2007 to 
January 2008. The results from this part are reported in paper 1 and paper 2. Part 
two included clinical examinations of a random sample of the questionnaire 
responders and was carried out from March 2009 to April 2010. Paper 3 and paper 
4 are based on data from this part.  
 
 
Study areas 
 
Vietnam is located in South East Asia (figure 6). The population has been rising 
rapidly despite governmental family planning and has increased from 54 million 
people in 1980 to 89 million in 2010 (figure 7).  
 
 
  
  
Figure 6. The location of the study areas 
 
 
The urban part of Hanoi is located in the Red River delta. Due to the low altitude 
and surrounding highlands, the heavy air pollution stays in the urban Hanoi.  
Further, urbanization is progressing very fast. The public transportation system 
doesn’t fulfil the requirements of the people why private vehicles are increasingly 
used, the major part being motorbikes. In urban Hanoi, the infrastructure doesn’t 
● 
Hoankiem ● 
Bavi 
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support the amount of transports resulting in traffic jams during the rush hours 
every day. 
 
The climate in Hanoi is a warm and humid subtropical climate with plenty of 
rainfalls typical for northern Vietnam. The summer, lasting from May to 
September, is hot and humid with an average temperature in July from 26
0
C-33
0
C, 
and the average humidity is 82%. The temperature can go up to 40
0
C. The winter 
period is short with an average temperature in January from 13
0
C - 19
0
C, and the 
average humidity is 78%. The temperature can go down to 6
0
C.  
 
 
 
 
Figure 7:  The Vietnam population from 1921 to 2008 
 
 
The study was performed in two areas of Hanoi, the urban inner city area 
Hoankiem, and the rural area of Bavi (figure 8). Hanoi is the capital of Vietnam.  
The choice of these two areas was based on the geographic composition of the 
areas, one urban and one rural, and differences in air pollution.  
 
Hoankiem is the biggest trading center but also the smallest district of Hanoi. The 
population in 2006 was 180,000 people and the population density was 32,703 
inhabitants/km
2
 in the 5.29 km
2
 area. Hoankiem is the old town of Hanoi with 
many small streets always full of vehicles, most of them motorbikes. There are 18 
wards in Hoankiem; 16 wards are located inside the Red River dyke system while 
the two biggest are located outside. Each ward has its own health care station 
which is under direct supervision of the Hoankiem District Health Care Center. 
There are 4-6 staffs in each ward health care station, including a medical doctor 
and nurses. In addition, each ward in Hoankiem has a team of 5-10 freelance 
citizens, often retired persons, who help as collaborators. Freelance citizens 
participated in collecting the data of the questionnaire survey.  
 
Bavi is located 60 km west of city center of Hanoi. In the past, Bavi was a district 
of the Hatay province. Hatay was emerged into Hanoi in 2008 and Bavi became 
the biggest rural district of Hanoi and includes lowlands, midlands, highlands and 
mountainous areas. The population in 2006 was 235,000 inhabitants. The major 
Unit: 1 000 people 
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part of the population is farmers and their income is based on agriculture and 
livestock breeding. There are 32 village health care stations in the Bavi district, 
one in each village and they are under the supervision of the Bavi District Health 
Care Center.  
 
 
  
Hoankiem district Bavi district 
 
Figure 8. The Bavi and the Hoankiem districts 
 
 
FilaBavi  
 
FilaBavi is a field laboratory for medical research of Hanoi Medical University 
and is located in the Bavi district. The sampling units are “population units” or 
“clusters” based on villages. The whole Bavi district has 352 clusters with a mean 
number of 146 households per cluster. The study population of FilaBavi consists 
of a sample of 67 clusters (51,000 inhabitants in 11,000 households) randomly 
selected proportionally to the population size in each of the geographical areas, 
i.e. lowlands, midlands, and highlands (Chuc & Diwan, 2003). 
 
 
Study population 
 
The study sample was randomly selected from the official register of the 
population in both areas. In Hoankiem, 4,000 were selected among 108,000 
inhabitants born from 1937 to 1986. However, 992 subjects in two wards located 
outside of Red River dyke were excluded because their addresses could not be 
traced (figure 9). In Bavi, also a sample of 4,000 people of same age was 
randomly chosen from the 51,000 subjects of the FilaBavi population. In total, the 
sample of both areas was 7,008 subjects. The age distribution of the invited 
subjects was from 21 to 70 years. 
 
 
Pilot study 
 
A pilot study was performed in order to know whether a postal survey was 
suitable in Vietnam. 250 subjects per area were randomly chosen from the original 
sample of 4,000 subjects. One month after the mailing only 10.2% had responded, 
and only 1 person had responded in Hoankiem. Among the 51 returned 
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questionnaires, five were answered by other persons than the invited. The 
conclusion was that a postal survey was not a suitable method in Vietnam.  
 
 
Questionnaire survey 
 
Instead of sending postal mails, we decided to personally deliver the 
questionnaires to the invited subjects. The trained field workers in of FilaBavi (46 
professional surveyors and 6 supervisors) and health care staffs and population 
freelance citizens at each ward of Hoankiem delivered the questionnaires to the 
invited subjects and asked them to complete the questionnaires.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In case participants could not complete the questionnaires by themselves, the field 
workers made a structured interview by reading the questions without any other 
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Figure 9. Flow chart of the study design and participation 
Pilot study 
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interfering or explanation to the subjects under study. Almost all questionnaires in 
Bavi were completed by surveyors, while in Hoankiem the majority of the 
questionnaires were completed by the participants. The questionnaire survey was 
conducted at the same time in Hoankiem and Bavi from September 2007 to 
January 2008.  
 
 
 
Clinical examination 
 
The sample invited to the clinical examinations was randomly chosen among the 
subjects who participated in the questionnaire survey. Totally were 1500 
randomly selected subjects invited, 750 from each area. The clinical study was 
conducted from March 2009 to April 2010 in both areas. 
 
The research team consisted of four medical doctors including myself and four 
research nurses, who all worked at the Department of Allergology, Hanoi Medical 
University or the Department of Allergy & Clinical Immunology, Bachmai 
hospital. The techniques of the skin prick testing, lung function measurements and 
methacholine testing were provided by the Swedish supervisors, who also trained 
the research team. Before the start of the study, the research team did several 
training sessions by themselves and also with the Vietnamese supervisor. The 
training was performed with volunteers, mostly medical students. All activities of 
the study were conducted at the local health care stations. The local health care 
staffs of Hoankiem and the field workers of the FilaBavi invited the study 
subjects. They also helped the research team in identifying the participants, 
completing the demographic information, measuring height, weight and blood 
pressure. All measures in Hoankiem were performed by the research team, 
however, in FilaBavi some field workers were trained also to do structured 
interviews. Most examinations were performed during weekends.   
 
 
Skin prick test 
 
All participants aged ≤60 years and not having contra indications were invited to 
skin prick testing.  
The contraindications were pregnancy, 
lactation or using anti-histamines 
within 3 days from the day of 
examination. Among of the 
participants, 537 subjects participated at 
the SPT; however results from four 
subjects were deleted due to a reaction 
to the negative control. Of all 
participants at the clinical 
examinations, 91 subjects (13.3%) did 
not fulfil the criteria for SPT including 
the age criterion and 56 people (8.1%) 
refused to do the test. 
 
 
 Figure 10. Allergens and 
equipments for skin prick test 
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The test followed the guidelines from the European Academy of Allergy and 
Clinical Immunology (EAACI) (Dreborg et al., 1989).The panel of SPT included 
ten well known airborne allergens: Cat, Dog, D. pteronyssinus, D. farina, 
Alternaria and Clasdosporium  were provided by Soluprick, ALK Hörsholm, 
Denmark, while Cockroach, B. tropicalis, Grass mixture (cocksfoot, sweet vernal 
grass, rye grass, meadow grass, timothy) and Tree mixture (maple, horse 
chestnut, plane, false acacia, lime) were provided by Stallergen Lab., France. 
Histamine 10 mg/ml and glycerol were used as positive and negative controls 
(figure 10). The reaction was read after 15 minutes. A wheal size ≥ 3 mm was 
regarded positive.  
 
 
Lung function, reversibility and methacholine test 
 
A portable spirometer (Multi-functional spirometer HI-801) was used for lung 
function testing. Calibration of the spirometer was performed daily with a 1 litre 
syringe. The test procedure followed the ATS recommendations (Laszlo, 2006). 
Spirometry was performed with the subjects sitting and using a nose-clip. Forced 
vital capacity (FVC) and forced expired volume in 1 second (FEV1) manoeuvers 
were performed at least three times and the difference between the two best FVC 
and the two best FEV1 values had to be <5%, or <1dl in case the values were <2 
litres. The subjects were instructed carefully how to perform the test before 
starting the measurements.  If the subject couldn´t achieve acceptable tests after 8 
manoeuvres, they got a short rest and new attempts were made. The reference 
values were taken from the equation calculated for the east Asian population. Of 
all tests, 570 lung function test results (83.3%) were accepted.  
 
The methacholine tests were performed with a nebulizer (Aliolos Systems) 
following the method developed at the Swedish OLIN studies (Lundback et al., 
1993). The recorded FEV1-value after inhalation of saline (0.9% NaCl) was used 
as the baseline FEV1. If the fall in baseline FEV1 was ≥10%, the subjects was 
labelled ‘saline reactive’ and the test was stopped and the subject was given 400 
µg Salbutamol. The methacholine concentrations used were 0.125, 0.25, 0.5, 1, 2, 
4, and 8 mg/ml. Each concentration was inhaled by normal breathing during 1 
minute. FEV1 was measured 2 minutes after each inhalation. The test was stopped 
when FEV1 had fallen ≥ 20% from baseline or after the last dose of methacholine. 
After that 400 µg Salbutamol was given and the lung function was re-measured 
after 20 minutes. The methacholine challenge was not performed if the subject’s 
FEV1 pre-test was < 1.5 l or < 60% of predicted. Furthermore, the challenge was 
not conducted if the subjects were > 60 years, had unstable heart disease or 
hypertension, or was pregnant or lactating, or could not cooperate.  
 
A reversibility test was performed in all subjects with 400 µg salbutamol via an 
inhaler. Spirometry was re-measured after 20 minutes.  
 
The lung function values used in the analyses were 
Forced vital capacity (FVC): The volume of air one can exhale with a forced 
exhalation after a maximal inhalation. 
First second forced expiratory volume (FEV1). The volume of air one can exhale 
during the first second using maximal force after a maximal inhalation (FEV1). 
The ratio of FEV1 and FVC was determined for defining airway obstruction. 
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Questionnaire 
 
The questions used in the questionnaire survey were taken from Swedish OLIN 
questionnaire (Lundback et al., 1991). The questionnaire has been used in several 
studies mainly in the Nordic and Baltic countries (Meren et al., 2001; Pallasaho et 
al., 1999). A recent version of the questionnaire has been published from a study 
in Helsinki, Finland (Pallasaho et al., 2006) and in Gothenburg, Sweden (E. P. 
Ronmark et al., 2009b). 
 
The interview questionnaire used was the recently developed GA
2
LEN Study 
questionnaire (Bousquet et al., 2009), which is mainly based on the ECRHS and 
the ARIA questionnaires (Biino et al., 2000; Cruz et al., 2007). Additional 
questions were taken from the Swedish OLIN-questionnaire (Lundback et al., 
1991). The questionnaire included questions mainly about respiratory and allergic 
symptoms, diagnoses, smoking habits, occupation, urban or rural childhood 
living, and living on a farm the first year of life.  
 
 
 
Definitions 
 
In this section the questions regarding the main diseases and symptoms are 
described. The questions of both the questionnaire survey and the structured 
interview are given in detail in the appendix. Several questions are identical in the 
self-administrated questionnaire and the structured interview.   
 
Self-administrated questionnaire (study part I) 
 
Physician-diagnosed asthma: “Have you been diagnosed as having asthma by a 
doctor?” 
Ever asthma: “Have you now or have you ever had asthma?”  
Asthma medicine: “Do you currently use asthma medicines (permanently or as 
needed)?” 
Physician-diagnosed chronic bronchitis: “Have you been diagnosed as having 
chronic bronchitis, COPD or emphysema by a doctor?” 
Ever chronic bronchitis: “Have you now or have you ever had chronic bronchitis, 
COPD or emphysema?” 
Allergic rhinitis: “Have you now or have you ever had allergic rhinitis (hay-fever) 
or allergic eye catarrh?”  
Recurrent wheeze: “Do you usually have wheezing, whistling or a noisy sound in 
your chest when breathing?” 
Any wheeze: “Have you at any time during the last 12 months had wheezing or 
whistling in your chest?”  
Wheezing with breathlessness apart from cold: “Yes”-answer to any wheeze and 
to –“Have you been at all breathless when the wheezing or whistling was present” 
and to –“Have you at any time had this wheezing or whistling when you did not 
have a cold?” 
Dyspnea: “Do you get short of breath when you walk with other people of your 
own age on level ground at normal pace?” 
Longstanding cough: “Have you had longstanding cough during the last year?” 
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Sputum production: “Do you usually have phlegm when coughing, or do you have 
phlegm in your chest which is difficult to bring up?” 
Chronic productive cough: Was defined as sputum production on most days 
during at least 3 months at least 2 successive years (please, see appendix). 
Family history of asthma and family of history of chronic bronchitis (please, see 
appendix).  
Family history of obstructive lung disease (OLD): “Yes”-answer to any of the two 
questions about family history of asthma and family history of chronic bronchitis.  
 
Structured interview questionnaire (study part II) 
Waken up by shortness of breath (SOB): “Have you been woken by an attack of 
shortness of breath at any time in the last 12 months?” 
AR symptoms last 12 months: “Have you been troubled by nasal allergies in the 
last 12 months?” 
Asthma attacks: “Have you had an attack of asthma in the last 12 months?”  
Asthma hospitalisation: “Have you ever been hospitalised for asthma?” 
Intermittent AR: If yes to AR symptoms last 12 months, “Have you ever been 
troubled by nasal allergies for more than 4 days in any one week?”  
Persistent AR: If yes to intermittent AR, “Did this continuously happen for more 
than 4 weeks?”  
Shortness of breath (SOB) when hurrying: “Do you get short of breath when you 
hurry on level ground or when you walk in your own pace up a stair or a small 
slope?” 
 
Allergic sensitization: A positive SPT-reaction to any of the allergens.  
 
COPD: Asian reference values of lower limit of normal for the ratio of FEV1/FVC 
have not been validated for Vietnam, thus the ATS/ERS standards for defining 
COPD could not been fully met while COPD was defined using the fixed ratio of 
FEV1/FVC ≤0.70 (Celli & MacNee, 2004). The highest FEV1 and FVC were used 
including post bronchodilator results. As no subject had exactly the ratio of 0.70, 
thus the results also were in line with the GOLD guidelines (GOLD, 2010).  The 
severity of COPD was also determined by the spirometric cut off values proposed 
by GOLD: 
 
GOLD 1 (mild COPD): FEV1/FVC < 0.70 and FEV1 % predicted ≥ 80 
GOLD 2 (moderate COPD): FEV1/FVC < 0.70; and 50 ≤ FEV1 % predicted < 80 
GOLD 3 (severe COPD): FEV1/FVC < 0.70 and 30 ≤ FEV1 % predicted < 50 
GOLD 4 (very severe COPD): FEV1/FVC < 0.70 and FEV1 % predicted < 30 
 
Due to few cases of severe and very severe COPD, these two groups were 
combined in the analyses.  
 
 
Smoking habits 
 
Current smokers were those who were current smokers at the time for the study or 
those who had stopped smoking within 12 months prior to the study.  
Ex-smokers were those who had stopped smoking more than 12 months prior to 
the study.   
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Non-smokers were those who never had been smokers or ex-smokers.   
1 pack year = 20 cigarettes per day for one year.  
 
 
Ethical issues 
 
The ethical issue was approved by the Ethics Committee of Hanoi Medical 
University in July 2006. Consent letters were received from the participants 
before carrying out the clinical examinations. 
 
 
Statistical analysis 
 
The data of the clinical examinations were checked one by one by the Swedish 
supervisors before computerising. The SPSS version 16.0 or PASW 18.0 was used 
for statistical analyses. Uni-variate analysis was performed using the χ2 test. One 
way analysis of variance (ANOVA) and χ2 were used for test of trends. Data from 
the initial questionnaire survey was used for paper 1 and paper 2 and also for 
evaluating the representativeness of the participants of the clinical study. A p-
value <0.05 was considered statistically significant. Risk factors for diseases, 
symptoms and allergic sensitization were calculated by using multiple logistic 
regression analysis. Demographic and exposure data were used as independent 
variables. They included sex, age, area, smoking habits, occupational exposure to 
dust, gases and fumes, and being raised on a farm during the first year of life. The 
results are expressed as odds ratios (OR) with 95% confidence intervals (CI).  
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RESULTS 
 
 
Part 1: Questionnaire survey (Paper 1 and Paper 2) 
 
 
Participation and smoking habits 
 
The participation rate of the questionnaire survey was 82.5% ranging from 70.3% 
in the urban Hoankiem to 91.7% in the rural Bavi. The participation rate was 
similar in men and women, and there was no major difference by age.  
 
Nearly two thirds, 61.0%, of the men but only 2.3 of the women in the study were 
current smokers.  Interestingly, there were differences in smoking habits between 
the urban and the rural area, more men but fewer women in the rural area were 
current smokers than in the urban area, p<0.001 for both comparisons (figure 6). 
The prevalence of ex-smokers was low in both areas, 1.7% in Hoankiem and 3.9% 
in Bavi.  
 
 
  
 
Figure 11. Smoking habits by area in men and women 
 
 
Prevalence of respiratory symptoms and diseases 
 
The prevalence of asthma ever was higher in Hoankiem, 5.6%, than in Bavi, 3.9% 
(p=0.003), while the prevalence of physician-diagnosed asthma was similar, 3.9% 
in Hoankiem and 3.8% in Bavi. Both chronic bronchitis ever (6.2% vs. 4.6%; 
p=0.005) and physican-diagnosed chronic bronchitis (4.1% vs. 3.3%; p=0.016) 
were more common in Hoankiem than in Bavi. Interestingly, the prevalence of 
% 
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AR ever was three times higher in Hoankiem, 26.9%, than in Bavi, 10.0% 
(p<0.001).  
 
There was a significant association between smoking habits and asthma as well as 
physician-diagnosed chronic bronchitis. The highest asthma prevalence was found 
among ex-smokers (table 1). 
 
 
Table 1. Prevalence (%) of asthma and chronic bronchitis by smoking habits 
 
 
Smoke
r 
Ex-
smoker 
Non-
smoker 
p-value, 
test for trend 
Ever asthma 5.4 7.9 3.9 0.004 
Ph-diagnosed asthma 4.9 7.9 3.2 <0.001 
Ever chronic bronchitis 5.6 7.3 4.8 0.196 
Ph-diagnosed chronic bronchitis 3.9 6.7 2.9 0.006 
 
 
The most common lower airway symptom in both Bavi and Hoankiem was 
longstanding cough (18.1% vs. 12.0%, p<0.001), followed by sputum production 
(16.0% vs. 11.0%, p<0.001). Sputum production was more common among men 
than women (p=0.017) and in subjects above than subjects below the age of 45 
years (p =0.022). All symptoms common in asthma and use of anti-asthma drugs 
were low, 2.1%, and similar in both areas. No statistically significant difference 
between the two areas was observed for any wheeze during the last 12 months, 
5.1% in Hoankiem vs. 4.3% in Bavi. The prevalence of all respiratory symptoms 
increased with age. 
 
A half of the participants in the study had either chronic nasal blocking or chronic 
runny nose. Nasal blocking was more prevalent in Hoankiem than in Bavi, 40.2% 
vs. 31.0% (p<0.001). In contrast, no difference in prevalence of runny nose was 
found between the two areas.  
 
Those who had lived on a farm during the first year of life had lower prevalence 
of AR ever (p<0.001) and chronic nasal blocking (p=0.002) than those who did 
not spend their first year on a farm.  
  
The prevalence of all respiratory symptoms and diseases was higher among those 
who had AR ever, chronic nasal blocking and chronic runny nose compared with 
those who did not have these nasal conditions (p<0.001 for all comparisons). 
 
 
Multivariate relationships 
 
Both ex-smoking and current smoking were significant risk factor for physician- 
diagnosed asthma; OR 3.04 (95% CI 1.51-6.13) and OR 1.61 (95% CI 1.07- 2.42), 
respectively. In contrast, these smoking variables didn’t reach statistical 
significance physician-diagnosed chronic bronchitis. Current smoking was also a 
risk factor for long standing cough, OR 1.45 (95% CI 1.16- 1.80) and for chronic 
productive cough, OR 1.89 (95% CI 1.20-2.99). The prevalence of all respiratory 
symptoms and of physician-diagnosed chronic bronchitis was higher in subjects 
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aged >45 years. A family history of obstructive airway diseases was the major risk 
factor for all asthma and chronic bronchitis conditions. 
 
When including age, sex, area of domicile, exposure to gas, dust, and fumes at 
work place and smoking habits in the model, exposure to gas, dust and fume at 
work place appeared as a major risk factor for all nasal conditions. Living in the 
urban Hoankiem was associated with an increased risk for AR ever, OR, 3.94 
(95% CI 3.40-4.56) and chronic nasal blocking, OR, 1.62 (95% CI 1.44-1.81). 
Being a women versus being a men yielded an OR of 1.47 (95% CI 1.26-1.72) for 
chronic nasal blocking and an OR of 1.36 (95% CI 1.18-1.58) for chronic runny 
nose.  
 
 
 
Part 2: Clinical examination (Paper 3 and Paper 4) 
 
 
Participation and representativeness 
 
Of the 1500 invited, 684 subjects (45.6%) attended the clinical examinations, with 
a higher participation rate in Bavi, 57.5%, than in Hoankiem, 33.6% (p <0.001). 
Subjects above the age of 50 years were more likely to attend than younger 
subjects (53.1% vs. 41.4%; p <0.001). Similarly, more women, 49.5%, than men 
participated, 41.7%; p=0.002 (table 2). Among the 684 participants, 683 (99.8%) 
participated in the structured interviews, 570 (83.3%) in lung function tests and 
533 (77.9%) in skin prick testing. 
 
 
Table 2. Prevalence (%) of participants at the clinical examination by sex, 
area and age group  
 
    Participants   
    Yes No 
p-
value 
     Men 
 
41.7 58.3 0.002 
Women 
 
49.5 50.5 
 
     Hoankiem 
 
33.6 66.4 <0.001 
Bavi 
 
57.6 42.4 
 
     ≤ 50 y 
 
41.4 58.6 <0.001 
>50 y   53.1 46.9   
 
 
There were no significant differences in respiratory symptoms or diagnosed 
asthma or AR ever between those who had participated in the questionnaire 
survey and those who attended the clinical examinations. 
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According to the interviews, the prevalence of current smokers was 29.0%, and it 
was 63.0% among men and 0.5% among women, p<0.001. The men who were 
current smokers had an average smoking history of 17.9 pack-years. The 
corresponding figure for women was 12.2 pack-years. The prevalence of ever 
smokers was similar in the two areas and did not increase with age.  
 
Overweight was more common in Hoankiem than in Bavi, p<0.001 (figure 12). 
Further, more people in Bavi had a BMI <18.5 than in Hoankiem, p<0.001.  
Subjects aged > 50 years had a higher BMI than those aged ≤ 50 years, 13.3% vs. 
8.3%, p=0.033.  
 
  
Figure 12.  Prevalence (%) of BMI-categories in Hoankiem and Bavi 
 
 
Prevalence of allergic sensitization and its relation to respiratory conditions 
 
Of the 533 subjects who were skin prick tested, 180 subjects (33.8%) had a 
positive SPT to at least one allergen and 159 subjects (29.8%) were sensitized to 
any mite or cockroach. Thus sensitization to any animal, any pollen, or moulds 
contributed with only 4% units to the total prevalence of allergic sensitisation. The 
most common sensitizer was the storage mite B.tropicalis (22.9%), followed by 
D. pteronyssinus (13.3%), cockroach (13.1%) and D. farinae (10.5%) (figure 12). 
Only 6.8% were sensitized to any animal. Sensitization to any pollen (2.8%) and 
any of the two moulds (1.5%) was even more uncommon (figure 13).  
 
Among the sensitized, 40.0% reacted to a single allergen while 6.0% were 
sensitized to ≥5 allergens. Multi-sensitization was significantly more common in 
the urban area compared to the rural area (p=0.006). Similarly, multi-sensitization 
was more common among men than among women (p=0.004), while multi-
sensitization did not differ between subjects below and above the age of 45 years.   
 
Allergic sensitization was significantly associated for all groups of allergens, i.e. 
any animal, any pollen, any mite, any mould, and cockroach, with AR ever and 
symptoms of AR during the last 12 months. Even though, symptoms common in 
asthma were more common among the sensitized, the only significant associations 
between sensitization and symptoms were for asthma attacks with any allergen, 
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p=0.036, recurrent wheeze with any mite, p=0.039, and recurrent wheeze with any 
allergens, p =0.015.  
 
 
 
Figure 13. Prevalence (%) of positive SPT to the tested allergens 
 
 
Age ≤45 years were the strongest risk factor for having a positive SPT to any 
mite, OR 1.64 (95% CI 1.09-2.45) and to any allergen, OR 1.48 (95% CI 1.02-
2.59). Sensitization to any mite was further associated with exposure to gas, dust 
or fumes at work, OR 1.57 (95% CI 1.02-2.41). Male sex yielded an OR of 2.61 
(95% CI 1.16-5.86) for having a positive SPT to cockroach. Sensitization to the 
different air-born allergens were not dependent on urban living or childhood farm 
living. Smoking habits were not significantly associated with allergic 
sensitization.  
 
 
Prevalence and risk factors of COPD and relation to respiratory conditions 
 
The overall prevalence of COPD was 7.1% by using both the ERS/ATS standards 
and the GOLD criteria. The prevalence was 10.9% in men and 3.9% in women, 
(p=0.001). The prevalence of COPD increased with age, and was 2.3% below the 
age of 50 years, and it was 14.6% among those who were older than 50 years 
(p<0.001). The prevalence of COPD among subjects aged >50 years old was 
23.5% in men and 6.8% in women (p<0.001). 
 
Among men aged ≥60 years, the proportion of subjects having COPD was 
significantly associated with smoking habits (p=0.04; figure 9). At this age, nearly 
50% of current smokers had developed COPD. The prevalence of COPD 
increased also with the cumulative exposure to tobacco smoke defined as the 
number of pack years (p<0.001). Among the subjects with COPD, 48.6% had 
mild COPD, 37.8% moderate and 13.5% had severe or very severe COPD.  
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Figure 14. Prevalence (%) of COPD among men aged ≥ 60 years by smoking 
habits. 
 
 
Most respiratory symptoms as well as a previously diagnosed asthma and a 
previously diagnosed COPD were strongly associated with the severity of COPD.  
Among the subjects with COPD, 35% had a previous diagnosis of COPD and 
17.5% had a previous diagnosis of asthma. Further, 60% had longstanding cough, 
25% chronic productive cough, 45% shortness of breath associated with physical 
activity, and 35% used any drug for lung disorders.  
Among the subjects with COPD, the 
proportion having at least one of the 
symptoms longstanding cough, sputum 
production, chronic productive cough or 
wheezing during the last 12 months was 
high and increased by disease severity 
(table 3).  
 
When including sex, area of domicile, 
age and smoking habits combined in a 
multivariate statistical model, the 
combination of increasing age and ever  
  
Table 3. Prevalence (%) of any 
respiratory symptom by severity of 
COPD  
 
  % 
 COPD stage 1 77.8 
 COPD stage 2 85.7 
 COPD stage 3+4 100 
   
smoking appeared as the dominating risk factor for COPD. The age of 50-60 years 
and ever-smoking yielded an OR of 13.52 (95% CI 2.16-84.5). Age ≥ 60 years 
combined with ever-smoking yielded a risk of having COPD with an OR of 37.2 
(95% CI 6.28-220.6), while the risk for non-smokers aged ≥ 60 years for having 
COPD was 6.31 (95% CI 1.71- 23.3). Sex and area of domicile were not 
significantly associated with an increased risk of having COPD. 
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DISCUSSION OF METHODOLOGY 
 
 
 
 
The methods and study designs used in the study will be discussed in this section. 
Limitations, strengths of the study as well as non-response will be discussed. In 
addition, different types of bias, which may influence the results, will also be 
discussed.  
 
 
 
Study design and study population 
 
 
The study was a cross-sectional study performed in two stages aiming at estimate 
the prevalence and risk factors of the outcomes of interest for the given 
population. The study areas were chosen in order to adequately reflect the true 
epidemiology of the diseases under study in urban and rural northern Vietnam. 
Because the study was a cross-sectional study there was no information of the 
sequence of events, i.e. whether exposure occurred before or after the onset of 
disease. Thus the calculations of risks may express cause or consequence or even 
parallel phenomena, and this is particularly true when discussing risk factors that 
are not stable over time.  
 
Bias should always be considered as it might affect the study results. It is helpful 
to classify bias into three broad categories: selection bias, information bias, and 
confounding. Selection bias is a systematic error in a study that stems from the 
procedures used to select subjects and from factors that influence study 
participation.   
  
The study sample was randomly selected from the list of the official registers of 
the population described in the material and methods section. This method 
reduces or even avoids selection bias. The sample was determined after power 
calculations. It was supposed that the prevalence of diseases, i.e. asthma and 
COPD in the study might vary from about 4% to 6% and with the accuracy in 
each area of less than ±1% within the limits of the 95% confidence interval. A 
sample size of 4000 subjects was thus selected for each area and response rate was 
assumed to be about 75%. The 992 subjects living in the two wards located 
outside the Red river dyke, who were not possible to trace and were thus excluded 
from the study, may have some different characteristics compared to the 
reminding study sample of Hoankiem. An unknown proportion of the 992 subjects 
may be different for instance regarding socio-economic status, why the exclusion 
of these 992 subjects may have caused bias of the results. However, we do not 
believe that a major bias was caused. The invited subjects in the questionnaire 
survey surpassed the size of the population samples used in the ECRHS, which 
varied from 3000 up to 6734 subjects (ECRHS, 1996). Furthermore, the response 
rate in our study was high, 82.5%, thus increasing the validity of the results and 
reducing bias caused by non-participation.  
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In the beginning we planned to perform the questionnaire survey as a postal 
survey following a protocol that has been used in several studies in northern 
Europe (Lunback et al., 1991; Meren et al., 2001; Pallasaho et al., 1999) . This has 
been a suitable, cheap and successful method for collecting data from large 
population samples. However, this method has rarely been used in Vietnam. We 
thus performed a pilot study using mailed questionnaires to 250 randomly selected 
subjects out of the 4000 from each of the two areas. The results from the pilot 
study confirmed our concerns, since only 10% returned the questionnaires, 
further, among them 10% of the questionnaires were answered by other than the 
invited subjects. Even though the prevalence of illiterate subjects in Vietnam is 
very low, specific questions regarding symptoms of medical conditions may be 
difficult to understand. This may be one reason why the invited subjects did not 
answer the questions in the questionnaire. Lacking of personal number and often 
not up-dated addresses contributed to difficulties in recognizing the study 
subjects. A conclusion is that a postal questionnaire survey was not a suitable 
method for Vietnam.  
 
Instead of sending the questionnaires by mail, we thus decided to ask field 
workers to deliver the questionnaires directly to the invited subjects. The strength 
of this method was a high response rate, and the amount of missing data to 
specific question was low. However, the limitation of this method is that the field 
workers might have interfered to the study. The way that field workers explained 
the study and the questionnaire might have caused information bias.     
 
The response rate in the second part of the study was lower, 45.6%, compared to 
the questionnaire survey. However, as we invited 1500 subjects, more than 600 
subjects participated in the clinical part of the study. Due to the low participation 
rate in the clinical part, the representativeness was analysed in order to evaluate 
possible bias caused by non-participation. The participants of the clinical part had 
reported similar prevalence of symptoms or diseases in the questionnaire survey 
as all participants of the questionnaire survey. Thus the low response rate in the 
clinical examinations did not create a significant bias caused by non-participation. 
There are no definite recommendations of a minimal number of participants in 
clinical epidemiological studies. However, several studies have aimed at achieve 
at least 600 participants. Lower numbers result in even wider confidence intervals 
and risk analyses will be affected by insufficient power. International studies that 
have aimed at a participation of at least 600 subjects per centre include the 
ECRHS and the northern European FinEsS-studies (Burney et al., 1994; Pallasaho 
et al., 2006). 
   
In the clinical part, the older subjects yielded a higher participation rate than the 
younger (p<0.001), results in line with several other studies (Bjornsson et al., 
1994; Milenkovic et al., 2011). This could create bias because the older subjects 
may be more likely to have diseases, and an altered lung function, and thus might 
have contributed to higher prevalence of bronchitis symptoms and diseases which 
are age dependent, in this study bronchitis and COPD. However, by performing 
the analyses stratified by age, and by using multivariate risk analyses correcting 
for age, this kind of bias could be controlled.  
 
A limitation of the study was the lack of objective measurements regarding 
smoking habits, such as measures of cotinine in urine or blood. 
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Questionnaire and structured interview 
 
 
Most questions used in the questionnaire are well validated in several studies in 
developed countries all over the world, and the whole questionnaire is well 
validated in studies in northern Europe (Lundback et al., 2001; Pallasaho et al., 
2006). Further, the question about physician-diagnosed asthma and asthma 
symptoms have been evaluated by some detailed systematic reviews (Samet, 
1987; Toren et al., 1993). However, no validation studies have been performed in 
Vietnam, and as far as the author of this thesis now, not in south-east Asia. 
Differences in language can cause bias because of both translation and 
interpretation. The questionnaire was translated from English into Vietnamese and 
back to English before the printing of the final version. This might reduce 
misunderstanding and bias caused by translation. The population in Europe is 
familiar with the symptoms and diseases addressed by the questions in the 
questionnaire. However, the fully understanding of these questions may not have 
been easy for the Vietnamese people. The difference between the terms of 
symptoms and diseases may have created confusion. An example of this is the 
results of the prevalence of wheeze.    
 
According to several population studies, ‘wheezing’ is the most common 
symptom among asthma patients (Lotvall et al., 2009; Lundback et al., 1991; 
Pallasaho et al., 1999). The prevalence of wheeze in the questionnaire survey was 
very low and similar to the prevalence of asthma. This result yielded a suspicion 
of misunderstanding of the term by the participants. The prevalence of ‘any 
wheeze during the last 12 months’ obtained from the structured interview at the 
clinical examination was three times higher compared to the questionnaire survey 
result. Also the questions about family history of asthma and allergic rhinitis, 
respectively, caused confusion as several subjects also included themselves when 
answering the question. This has created the unexpected strong association of 
asthma and symptoms common in asthma with family history of asthma. Thus 
data about family history of disease have not been used in other papers than paper 
1.     
 
Recall bias, a common type of information bias, might have contributed to our 
study. The way to frame the time in the questionnaire such as ‘last 12 months’, 
‘last year’ could prevent this kind of bias. At the clinical examinations, the 
research team came from a big university and a big hospital. That may have 
attracted more attention among the participants. Furthermore, the clinical 
examinations including skin prick and lung function testing together with the 
structured interview might have contributed to the understanding of several 
questions, particularly of questions asking about occasional symptoms. This could 
at least in part explain why the prevalence of symptoms obtained at the clinical 
examinations was higher than at the initial questionnaire survey.  
 
The structured interview at the clinical examinations was conducted by the well 
trained research team, however with some exceptions. In Bavi, some of the field 
workers who conducted the first questionnaire part of the study contributed to the 
data collection by performing some of the structured interviews after being 
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carefully trained. Nevertheless, the use of field workers may have caused some 
inter-observer or information bias. On the other hand, FilaBavi is a field 
laboratory of Hanoi Medical University, and the staff of Fila Bavi has actively 
participated in several other similar studies. As the study was conducted all 
around the year in the two areas, seasonal bias of importance might not be a 
problem.   
 
 
 
Skin prick testing 
 
 
The results of skin prick testing (SPT) depend on the potency of the allergen 
extracts, the cut off limits for defining a positive test, and the techniques used. The 
SPT followed the guidelines of the European Academy of Allergy and Clinical 
Immunology, EAACI (Dreborg et al., 1989). The hot and high humidity climate in 
Vietnam causes a lot of sweating on the skin, why drawing of the results could 
cause difficulties in some subjects. Individual results could thus be biased caused 
by inexact measuring of the diameter of the weal. Further, the research team who 
performed the SPT was not exactly the same in Bavi as in Hoankiem. However, 
all who conducted the SPT were trained and were familiar with the techniques of 
performing SPT, which thus minimized the possibility of creating bias.  
 
Vietnam has no pollen mapping why it was difficult for the research team to 
adequately decide which pollen allergens that should be included in the test panel. 
The choice of German cockroach instead of American cockroach may have 
resulted in an underestimation of sensitization to cockroach. American cockroach 
is the predominant species in tropical countries with high temperature and 
humidity (Arruda et al., 2001). This has been discussed in the discussion of main 
results. 
 
 
 
Lung function and methacholine testing 
 
 
The lung function measurements were performed following the American ATS 
recommendations (Laszlo, 2006). The same equipments were used throughout the 
study, and the two spirometers were calibrated daily. The well trained research 
team performed all spirometric measurements which minimized a possible inter-
observer bias. 
 
Most participants in our study had never done lung function testing before. The 
research team encouraged the participants to do their very best when performing 
the test. Despite that, some bias may have occurred regarding mainly forced vital 
capacity, as some participants may have presented an incomplete blowing out. An 
eventual bias caused by that may have resulted in an underestimation of the 
prevalence of COPD. A detailed control of the lung function test results by the 
supervisors resulted in further training of the research team, and the technique 
became better. All subjects who failed in performing the lung function test with an 
acceptable technique were re-invited for a new test, and 50 subjects had to re-do 
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the test. If they did not attend or could not present a test with an acceptable 
technique, their test results were deleted.  
 
The methacholine challenge testing was performed following a method develop 
by the OLIN studies in northern Sweden (Lundback et al., 1993). All 
methacholine tests were conducted by only four persons from the research team, 
thus minimizing possibilities of inter-observer bias. As the test was time 
consuming, some subjects interrupted the test or refused to do the test why the 
participation rate at the methacholine testing became not optimal.  
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DISCUSSION OF MAIN RESULTS 
 
 
 
 
Our study was the first large scale-study about respiratory symptoms and diseases 
including allergic sensitization performed among adults in rural and urban 
northern Vietnam. The aim of this epidemiological study was to estimate the 
prevalence of respiratory symptoms and diseases, such as allergic rhinitis, asthma, 
chronic bronchitis and COPD, and also of allergic sensitization. Further aims 
include studies of risk factors for the conditions including smoking. The 
questionnaires and protocols were based on validated questionnaires and protocols 
concerning respiratory conditions and smoking habits that have been conducted 
mainly in Europe. Some modifications of the methods were needed in order to 
make the study possible to be conducted in Vietnam.  
 
 
 
Participation 
 
The number of subjects that were not possible to trace was high in the urban area. 
The Hanoi city population register is not regularly updated, and information about 
inhabitants who have moved, changed address, or have deceased, is often not 
available. Nearly 1000 subjects who lived in two wards or areas located outside 
the Red River dyke system in Hoankiem were excluded, as a large proportion of 
them were not possible to trace.  
 
The large variation in participation rates between different countries and study 
centers may be a result of different cultural and societal attitudes. The response 
rate in the questionnaire part of the study was 82.5%, which corresponds closely 
to the 90.5% and 77.6% response rates of the northern Sweden and Estonia 
studies, respectively (Lundback et al., 1991; Meren et al., 2001).  However, the 
participation rate at the clinical examinations was lower, 46.5%, compared to 
studies performed in northern Europe (Lundback et al., 1993; Pallasaho et al., 
2006; Kotaniemi et al., 2005). Our low participation rate may partly be a 
consequence of the fact that most clinical examinations were performed during 
weekends. At weekends, the study subjects, most of them healthy, might prefer to 
relax or to do private activities rather than go to health care centers for 
participation in a study. The distance from their homes to the health care centers 
was another obstacle, especially in some villages in the mountain area, since the 
transport system has limitations. Furthermore, not all subjects had access to a 
telephone, so it was not possible to remind them about the date of the clinical 
examination. This might have contributed to the low participation rate. In 
addition, the tests were time consuming and perceived complicated, why some 
subjects refused to attend.  
 
In the first part of the study, the questionnaire survey, no difference in the 
participation rate was observed regarding sex and age, a result in line with studies 
in northern Sweden in 1980s (Lundback et al., 1991). In the clinical examinations, 
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women and older subjects participated generally more frequently, as was the case 
in health surveys in northern Europe (Bjornsson et al., 1994; Meren et al., 2001; 
Warm et al., 2011).   
 
 
Smoking 
 
Among Vietnamese men, 61% were current smokers. The prevalence of smoking 
among men in Vietnam was the highest in the Asia Pacific region, since the 
prevalence of current smoking among men in China, Thailand and Cambodia was 
53%, 42%, and 48%, respectively (Li et al., 2011; Mekrungrongwong et al., 2011; 
Singh et al., 2009). Luckily, women’s tobacco use is currently still much lower 
than it is for men. This reflects the social, cultural, and traditional beliefs that 
discourage them from smoking. Still being influenced by the traditional values, 
the Vietnamese do not easily accept the image of a smoking woman. The validity 
of the reported smoking prevalence in women might, however, be far from true. 
Following a study in Korea using urinary cotinine concentrations to define 
smokers, the number of self-reported female smokers was less than a half of 
cotinine verified smokers (Jung-Choi et al., 2011). However, the prevalence of 
smoking among women in Asia is following the western trend, with more women 
take up smoking while men quit. Smoking among the youth in Malaysia increased 
from 5% in 1996 to 8% in 1999 and to 17% in 2009 (Abdulah, 1999; Al-Naggar 
et al., 2011).  
 
Tobacco smoking is by far the most important risk factor for most respiratory 
conditions. Active smoking has been identified as the major causal risk factor for 
the development of COPD (GOLD, 2010). As expected, the prevalence of COPD 
in or study was associated with smoking. Fifty percent of smoking men over the 
age of 60 years fulfilled the spirometric criteria of COPD, results in line with 
studies conducted in USA and Europe (Kotaniemi et al., 2005; Lundback et al., 
2003; Stang et al., 2000). Further, the prevalence of COPD increased with the 
number of cigarettes consumed, also this result was similar to other studies 
(Schirnhofer et al., 2007). Respiratory symptoms were also significantly 
associated with smoking. Also this result was in line with other studies 
(Lindstrom et al., 2001; Lundback et al., 1991). The relatively high prevalence of 
longstanding cough and sputum production might reflect the burden of smoking 
habits in the Vietnamese population.  
 
Asthma and chronic bronchitis were also associated with smoking. The prevalence 
of these diseases was relatively high among ex-smokers, even though the number 
of ex-smokers was low. Regarding asthma, this result is in accordance with results 
from several cross-sectional and other studies (E. Ronmark et al., 1997). Probably 
the smokers quit smoking after having developed respiratory symptoms. After 
smoking cessation, the decline in FEV1 levels off but without a return of FEV1 to 
the basal levels (Fletcher & Peto, 1977). There is a clear evidence from the US 
Lung Health Study that smoking cessation modifies the decline in lung function 
(Au et al., 2009). That study clearly showed smoking to be a modifiable risk 
factor for morbidity and mortality. The US Lung Health Study showed further that 
by quitting early, lives can be saved. Smoking cessation is of proven benefit at 
any age, but the benefits are greatest for those who stop smoking before the age of 
35 years.  
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Asthma 
 
The burden of asthma and AR is recognized as an important public health 
problem. The Global Initiative for Asthma (GINA) reports adult asthma 
prevalence ranging from 5-18% all over the world (GINA, 2010). AR is even 
more common than asthma and affects 10-20% or even more of the population 
worldwide (Bousquet et al., 2008).  
 
The prevalence of ever having had asthma was reported higher in urban 
Hoankiem than rural Bavi, 5.6% vs. 3.9% (p =0.003). Similarly, the prevalence of 
AR was reported three times higher in urban Hoankiem than in rural Bavi, 29.6% 
vs. 10.0% (p<0.001). This very large reported difference will be discussed later in 
this part of the thesis. Furthermore, living on a farm for the first year of life 
yielded a lower prevalence of AR compared to those who had not. This result 
might refer to the increase in allergic diseases associated with urban living. The 
differences in prevalence of allergic disease between urban and rural areas have 
been observed in many parts of the world. In a developing country, Mongolia, a 
low prevalence of allergies was found in rural areas and an increase in prevalence 
was found parallel to increasing urbanization (Viinanen et al., 2005). Other 
studies have also pointed out that populations living in rural areas experience a 
low burden of allergic diseases (Cingi et al., 2005). Such studies offer an excellent 
framework to investigate the potential risks on one hand and protective factors on 
the other.  
 
There are several factors related to urban living that may increase the prevalence 
of allergic diseases. These factors include exposure to outdoor and indoor air 
pollution and sensitization to several allergens such as cockroach, dust mite, 
mouse, and rat allergens (Gunnbjornsdottir et al., 2009; Nicolaou et al., 2005). Air 
pollution is a consequence of industrialization and urbanization, largely caused by 
emissions from transportation, manufacturing, and power production. Air 
pollution adversely affects the entire population living in urban settings. Above 
that there are subgroups that have increased susceptibility to the adverse effects of 
poor air quality. Among others, the findings of a study suggested that even at low 
concentrations, indoor pollutants could be of importance in asthma. The authors 
also showed that urban dwellings were found to be more polluted than rural ones 
(Hulin et al., 2010). The hygiene hypothesis theory is used for trying to explain 
the difference in prevalence of allergic diseases between urban and rural areas 
(Bloomfield et al., 2006).  
 
In studies of prevalence of asthma during the 1980s and early 1990s among adults 
in Europe, the estimates of prevalence were of similar magnitude as in our study 
that was performed 15-20 years later than these studies. In northern Sweden the 
prevalence in mid 1980s was 5% (Lundback et al., 1991) and in southern Sweden 
in 1992 the corresponding prevalence was around 6% (Montnemery et al., 1998). 
In Italy in mid 1980s the corresponding prevalence was on a similar level (Paoletti 
et al., 1989), and also in Australia 5-6% of adults had asthma during that time 
period (Woolcock et al., 2001). In early 1990s the European Community 
Respiratory Health Survey (ECHRS) found the asthma prevalence varying from 
1% in East-Germany up to 11-13% in Australia and New Zealand (Janson et al., 
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1997). Later on, a higher prevalence, 8-10%, of adult asthma has been reported 
from several developed countries including Sweden (Ekerljung et al., 2010b; 
Lotvall et al., 2009). 
 
After the millennium shift, high prevalence of asthma has been reported also from 
some countries in south-east Asia. In one study from Thailand, 11.6% were 
identified as having physician’s diagnosed asthma (Uthaisangsook, 2010). 
Compared to other studies in Pacific Asia performed in 1990s, such as in China 
and Singapore, the prevalence of asthma in our study was higher (Chan-Yeung et 
al., 2002; Ng, 1999). A study in Dalat, a highland city in southern Vietnam, found 
the prevalence of asthma and asthma like symptoms to be rather low, 2.4% (Sy et 
al., 2007). The above results confirmed that the prevalence of asthma varies 
between countries and also between areas within countries, and further, that the 
prevalence in south-east Asian countries (Quah et al., 2005) nowadays reach the 
same level as in Europe and Australia 15-20 years ago. However, different 
methods and definitions make comparisons difficult.  
 
 
 
Allergic rhinitis 
 
The prevalence of AR in urban Hoankiem was close to 30%. This result was as 
high as in several developed countries. A cross sectional survey based on an adult   
French general population sample showed that the overall prevalence of AR was 
31% (Klossek et al., 2009). A recently estimated prevalence of AR both in 
Gothenburg and Stockholm, Sweden was 28% (Eriksson et al., 2011). Also in 
Bangkok, Thailand, using the ISAAC questionnaire among university students, 
the prevalence of AR was high, 26% (Vichyanond et al., 2002). According to a 
study in Japan, the prevalence of AR among men was 36% (Sakurai et al., 1998). 
All the above studies showed the prevalence of AR to be similar to the prevalence 
of AR in urban Hoankiem in our study. In other areas of east Asia a considerably 
lower prevalence of AR has been found. For instance a study in South Korea 
reported the prevalence of AR to vary from 6% to 10% (Park et al., 2009), which 
is similar to or even lower than the prevalence of 10% in rural Bavi in our study. 
In a cross-sectional study in 11 major cities in China, the prevalence of self-
reported AR was lowest in Beijing, 8.7%, and highest in Urumqi, 24.1%, 
indicating an inverse result regarding the commonly found urban-rural difference 
(L. Zhang et al., 2009).  
 
The awareness of AR may be poor in developing countries, and probably even 
poorer in rural areas such as in Bavi in our study. Vietnam is a tropical country 
with a high temperature and a high humidity. Common colds caused by viruses 
happen all around the year. Sneezing, scratchy throat, runny nose are symptoms of 
common cold that exist normally less than one week. The high prevalence of AR 
in Hoankiem might partly consist of a number of mild common colds that often 
are ignored in rural areas. This concern is supported by the rather similar 
prevalence of rhinitis symptoms, such as runny nose and nasal blocking in both 
Bavi and Hoankiem.  
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Allergic sensitization 
 
With the current study, we could present the pattern of allergic sensitization 
among adults in northern Vietnam. Mite and cockroach were the most important 
sources of allergic sensitization in northern Vietnam. We found that 29.8% of the 
subjects were sensitized to any mite or cockroach, and 33.8% had a positive SPT 
to at least one of the tested allergens. Our study contributed to the findings that 
mites and cockroach are the most common sensitizers in the world (Ghaffari et al., 
2010).  
 
The most common sensitizer in our study was the storage mite, B. tropicalis 
(22.9%), followed by D. pteronyssinus (13.3%) and D. farinae (10.5%). A 
previously performed study among schoolchildren in a rural area of the middle 
part of Vietnam found a similar prevalence of sensitization to house dust mites, 
14.4% (Flohr et al., 2006). Our study underlines the importance of allergens from 
the storage mite families. These allergens have 70% amino acid sequence 
disparity compared with the Dermatophagoides family, why there is only a 
minimal IgE cross-reactivity. B. tropicalis, found mainly in South America, the 
Caribbean and in Asia, is the most important mite among the storage mites and 
usually occurs in conjunction with D. pteronyssinus. In a study in Singapore, B. 
tropicalis was the dominating sensitizer determined by SPT in patients with 
asthma or allergic rhinitis, and 96% of them were sensitized to B. tropicalis 
(Chew et al., 1999). Similarly, sensitization to B. tropicalis among allergic 
patients in Indonesia was high, 72% (Baratawidjaja et al., 1999).  
 
The predominant sensitizers in most countries, D. pteronyssinus and D. farinae 
coexist in most geographical regions. D. pteronyssinus prefers temperate and 
tropical coastal regions, whereas D. farinae is more abundant in continental 
climates. The allergens of D. pteronyssinus and D.farinae typically have 15–20% 
amino acid sequence disparity but they also have unique epitopes, although they 
are immunologically cross-reactive. House dust mites are the most common 
source of allergy all over the world (Akdemir & Yilmaz, 2009). Further, mites are 
important sources of sensitization to indoor allergens associated with asthma as 
well as with other allergic conditions including allergic rhino-conjunctivitis and 
atopic eczema (Y. K. Kim et al., 2002) . In Vietnam, Sy DQ found that 50% of 
atopic subjects had at least one positive skin prick tests to D. pteronyssinus, D. 
farinae, or B. tropicalis (Sy et al., 2007). In our study, allergic sensitization was 
significantly associated with AR but less so with asthma even though asthma 
symptoms were more common among the sensitized subjects.  
 
In regions with poor sanitary or socio-economic conditions, also cockroach is one 
of the most common indoor allergens. In the United States, the prevalence of 
allergic sensitization to cockroach range from 21% to 35% among children with 
asthma depending on rural or urban living (Matsui et al., 2003). In Estonia, the 
prevalence of sensitization to cockroach was 16% (Raukas-Kivioja et al., 2003). 
In Thailand, 13% of female high school students had a positive SPT to cockroach 
(Prasarnphanich & Sindhurat, 2005), moreover, 43% of middle schoolchildren 
with asthma in Taiwan were sensitized to cockroach (Lin et al., 2002). In our 
study 13% had a positive SPT to cockroach (B. germanica). The same prevalence 
of sensitization among adults to B. germanica species was found in the highland 
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city of Dalat in Vietnam (Sy et al., 2007).  When using another cockroach species, 
P. Americana, the prevalence of sensitization among Vietnamese schoolchildren 
was 27.6% (Flohr et al., 2006).   
 
There are two common domiciliary cockroach species: Blattella germanica 
(German cockroach) and Periplaneta americana (American cockroach). B. 
germanica is a small cockroach that commonly infests houses in United State.  P. 
Americana is a bigger cockroach that requires higher temperatures and higher 
humidity for optimal population growth. In Vietnam, we have not performed any 
study to explore which domiciliary cockroach is the most common. Based on the 
climate, the most common species of cockroach is probably the American 
cockroach. Choosing German cockroach might be the reason to the relatively 
moderate prevalence of sensitization to cockroach in our study.   
 
In cold and dry areas, such as Finland, northern Sweden and parts of Norway, 
mites are uncommon, and the most common sensitizers are cat, dog and pollen 
(Bakken et al., 2007; Pallasaho et al., 2006; E. Ronmark et al., 2009a). In our 
study, the prevalence of positive SPT to pollen was particularly low, 2.8%. In 
Malaysia, different pollen allergies were observed in urban areas, but none of 200 
subjects with asthma was found to be allergic to pollen alone (Sam et al., 1998). 
Furthermore, the prevalence of sensitization to pollen in China varied from 0.5 to 
5% (Z. G. Liu et al., 2010). However, of asthmatic children in Thailand, 30% 
were sensitized to different pollens from grasses or trees (Kongpanichkul et al., 
1997) Although pollens do not belong to the major sensitizers in the tropical zone 
where climatic variations are attenuated, sensitization to pollen is thus of clinical 
importance also in south-east Asia.  
 
 
Bronchitis and COPD 
 
We found in this population based survey among adults in Hoankiem and Bavi a 
high prevalence of bronchitis symptoms. The prevalence of bronchitis symptoms, 
such as longstanding cough and sputum production, was similar to what has been 
reported in several westernised countries (Lundback et al., 1991; Meren et al., 
2001; Pallasaho et al., 1999). This may be related to the smoking prevalence in the 
society.  
 
Worldwide, COPD is one of the leading causes of chronic morbidity and mortality 
(GOLD, 2010). In developing countries, chronic respiratory diseases represent a 
challenge to public health because of their frequency, severity, projected trends 
and economic impact. Still relatively few population studies on COPD have been 
conducted in Asia, where the burdens of smoking and the use of biomass fuel for 
cooking and heating houses are high. Even though there are some well 
documented studies of COPD in Asia, it is not easy to make comparisons due to 
the use of different study methods including different age compositions of the 
study samples, different recruitment strategies and different diagnostic criteria. 
We found the overall prevalence of COPD in our study to be 7%.   
 
In Austria, a population based survey among adults aged ≥40 years using the 
BOLD study design and protocol yielded a very high prevalence of COPD, 26% 
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(Schirnhofer et al., 2007). Following a study in the Philippines also using the 
BOLD protocol, the prevalence of COPD in rural areas was 21% (Idolor et al., 
2011). It is hard to find reasons to the very high prevalence of COPD in Austria. 
The high prevalence of COPD in Philippines may be a consequence of a high 
prevalence of previous TBC, high prevalence of smoking, and the common use of 
wood for cooking. Lower estimates of prevalence of COPD have been reported 
from Japan, China and South Korea. A study in Japan presented a prevalence of 
11% using the GOLD criteria (Fukuchi et al., 2004). A Chinese study found the 
prevalence of COPD to be 8% (N. Zhong et al., 2007), and in South Korea only 
4% were found to have COPD in a population survey (S. J. Kim et al., 2006). 
 
 
 
Figure 15. The Vietnamese population pyramid for 2010; distribution by age 
and sex 
 
 
Using the GOLD criteria, the prevalence of COPD in Sweden was 14% (Lindberg 
et al., 2005). The apparently low overall prevalence of COPD in our study, 7%, is 
due to the very young population of Vietnam (figure 15). When stratified by age, 
the prevalence  of COPD increased considerably by age with 14.6% fulfilling the 
spirometric  GOLD criteria of COPD among those aged >50 years, a result close 
to identical to what has been found in another study in northern Sweden 
(Lundback et al., 2003). This finding illustrates the magnitude of the burden that 
COPD will pose in Vietnam in near future, as the proportion of elderly people in 
the population is increasing continuously.  
 
The risk for COPD increases considerably with increasing age and cumulative 
exposure to smoking. Among men older than 60 years in our study, nearly 50% of 
smokers had developed COPD. This result is in line with other studies in Europe 
and USA (Lundback et al., 2003; Mannino et al., 2000). Consistent with the 
present understanding of the role of smoking, as found by others (Schirnhofer et 
al., 2007), also we found a strong dose-response relationship with pack-years of 
smoking.  
 
Nevertheless, we also found that 30% of the COPD cases were women, and all of 
them were non-smokers. These findings suggest that mechanisms or risk factors 
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other than own smoking may play a role in the development of COPD. Using of 
biomass including wood, dung and crop residues for heating and cooking is 
widespread in developing countries. There are several studies that have found the 
use of biomass fuel or solid fuel to be a risk factor for COPD (Hu et al., 2010). 
This association was mostly attributed to women since they had, and still have, 
the responsibility for cooking in developing countries. In our study we could not 
verify this relationship probably due to the small number of COPD cases among 
women, and further, all women in the rural area were exposed to fume from 
biomass, and this was the case also for a large proportion of women in the urban 
area. Furthermore, environmental tobacco smoke may contribute to COPD among 
Vietnamese women. The smokers in Vietnam are free to smoke inside their 
homes, and they also smoke inside public places despite the fact that a smoking 
ban was introduced in 2010.  
 
In our study, the prevalence of respiratory symptoms increased by severity of 
COPD. Among those with severe and very severe COPD, all had at least one 
chronic respiratory symptom, a result similar to what was found in the studies in 
northern Sweden (Lindberg et al., 2006). Similar to European studies (Lindberg et 
al., 2006; Schirnhofer et al., 2007), also in our study only 35% of subjects with 
COPD had a previous diagnosis of COPD. It means that the underdiagnosis of 
COPD is high in Vietnam, however, the underdiagnosis is high worldwide. The 
results of our study suggest that the prevalence of COPD among smokers in 
Vietnam is even higher than previously believed. It would be beneficial for all 
smokers to undergo spirometry testing on an annual basis, and doctors should 
urge their patients who are smokers to be submitted to such a test. Such screening 
could make a tremendous difference in the outcome of the disease. Earlier 
diagnosis through targeted case-finding would allow early, aggressive smoking 
cessation efforts and might lead to a reduction in the burden of COPD morbidity, 
and to a reduced impact of the disease on health related quality of life in these 
patients (Gilljam, 2007). However, spirometry in Vietnam is not performed 
routinely in medical practice due to lack of specialized technicians, doctors and 
equipments. It is why most COPD patients cannot be diagnosed early in the 
disease process.  
 
 42 
 
CONCLUSSIONS 
 
 
 
 
The most common respiratory symptoms in northern Vietnam were long standing 
cough and sputum production. The prevalence of ever having had asthma was 
higher in the urban area compared to the rural, 5.6% vs. 3.9%, p=0.003. Also 
chronic bronchitis ever, 6.2% vs. 4.6%, p=0.005, was more common in the urban 
area. Among men, 61% were current smokers vs. 2.3% among women. Asthma, 
chronic bronchitis and bronchitis symptoms were all associated with smoking. All 
respiratory symptoms increased by age. 
 
Self-reported AR was considerably more common in the urban area compared to 
the rural, 30% vs. 10%, p<0.001. About 50% had either chronic nasal blocking or 
chronic runny nose. Being women was associated with chronic nasal blocking and 
chronic runny nose, and living in the urban area was associated with chronic nasal 
blocking. All respiratory symptoms and diseases were more common among those 
with allergic rhinitis, chronic nasal blocking and chronic runny nose compared 
with those not having the nasal conditions.  
 
Among the skin prick tested subjects (age ≤60 years), 34% were sensitized to at 
least one airborne allergen, and 30% were sensitized to either mites or cockroach. 
The storage mite, Blomia tropicalis, was the main sensitizer followed by house 
dust mites and cockroach. Pollen and moulds were no major sources of allergic 
sensitization, and only 2.8% and 1.5%, respectively, were sensitized to these 
allergens. Allergic sensitization was significantly associated with allergic rhinitis, 
but less so with asthma. Young age was a risk factor for having a positive SPT to 
at least one allergen and to sensitization to mites. Exposure to gas, dust or fumes 
at work yielded an increased risk for sensitization to any mite. 
 
The overall prevalence of COPD was 7.1%, (men 11% vs. women 3.9%, p=0.001) 
by using the fixed ratio definition of both ERS/ATS standards and the GOLD 
criteria, and 1.2% had a severe or very severe COPD. COPD was significantly 
associated with increasing age and among men with smoking, while no women 
with COPD had ever been a smoker. Among men, COPD was strongly associated 
with increasing number of pack-years. Among men ≥60 years old, nearly 50% of 
current smokers had developed COPD.  
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PERSPECTIVES 
 
 
 
 
When I came to Sweden, I realised that it was a paradise for scientific studies. I 
have learned a lot not only about research methodology but also about scientific 
thinking. The way how to conduct a study in Vietnam is in principle more or less 
similar to methods in other countries. However, when I conducted the study in 
Vietnam, I found that we still have some difficulties when performing large scale 
population studies. There are steps that have to be changed. A publication of ‘how 
to perform an epidemiological study of respiratory diseases in Vietnam’ would 
enhance our knowledge about methods that are suitable for use in Vietnam. It 
would help us to identify weaknesses as well as to clarify strengths of those kinds 
of the studies.  
 
Detailed information about exposure from indoor use of biomass fuels is 
important for analysing effects on airway diseases. The burden of smoking among 
men in Vietnam is enormous resulting in a high environmental tobacco smoke 
exposure not only on women and children but in the whole society. A publication 
about passive smoking and respiratory diseases should be written based on the 
collected data. Furthermore, intervention studies on smoking cessation and 
smoking prevention programs particularly in school children and teenagers would 
be important to reduce the risk of developing lung and airway diseases, and also 
of several other diseases such as cardiovascular diseases and cancer.  
 
There are limited data about the prevalence of airway hyper-reactivity in Vietnam. 
In this thesis, I have only used parts of the results of hyper-reactivity to 
methacholine. From the cross-sectional study such results are ready to be analysed 
and published. An important question that should be answered is whether asthma 
is underdiagnosed in Vietnam. Thus the association between hyper-reactivity and 
the diagnosis of asthma in Vietnam deserves to be evaluated.   
 
The results of this thesis were based on cross-sectional data. In future, 
longitudinal studies of relevant populations are required to know incidence of 
disease and for calculation of valid risks. Large studies are required to ensure that 
the associations can be explained by risk, rather than by chance.   
 
 
 
 
 
 
 44 
ACKNOWLEDGEMENTS 
 
 
 
 
 
I wish to express my sincere gratitude to all those who have contributed in many 
ways to my PhD period and this thesis. I want to thank all study responders in 
Bavi and Hoankiem who made this thesis possible by participating in the study. 
Particularly, I would like to thank: 
 
Bo Lundbäck, my main supervisor, for unlimited supports. Thank you very much 
for finding time in your busy schedule for me when needed. I have deeply 
admired your brilliant advice and guidance. I also would like to thank your whole 
family for the hospitality during my visits in Umeå. What I have learned from you 
is not only scientific thinking but also human behaviour not only for the scientific 
sides but also for the living matters. 
 
Eva Rönmark, my co-supervisor, for your excellent scientific knowledge and 
valuable discussions. Thank you very much for your encouragement in research 
and training and your great efforts in revising my papers and thesis. Thank you 
very much for your friendship and to showing me the Swedish culture, especially 
during the periods was in Luleå with you and your family. I also would like to 
thank you for letting me to stay with you at your beautiful house. I really 
appreciate your hospitality and how you made me feel right at home. 
 
Kjell Larsson, my co-supervisor, for your valuable advices and arrangement for 
my whole PhD student period at the Unit of Lung and Allergy Research at 
Institute of Environmental Medicine. Thank you for being very helpful always 
when needed.  
 
Nguyễn Văn Tường, my Vietnamese supervisor, for your generous support and 
kindness encouragement. Thank you very much for let me join the common 
diseases program family and for accepting me as your PhD student. I thank for 
your training of my research team. 
 
Ingeborg van der Ploeg, co-ordinator of the common diseases program, for all 
your help. Thank you for showing me Stockholm and taking care of me 
particularly at the beginning of my PhD student period.  
 
Lena Palmberg, my best friend, thank you for opening yourself up to me. Thank 
you for helping me when preparing all things needed for the dissertation. Thank 
you very much for the jocular chat in between the working time at our department. 
Your warm friendship has made me feel at home when being in Sweden.  
 
Linda Ekerljung for helping me with analyses of data, co-authorship, and for 
being my friend during my first years at the Unit of Lung and Allergy Research 
and during the time I have been in Gothenburg.  
 
   45 
Nguyễn Thị Kim Chúc, Nguyễn Bình Minh, Ngô Thị Thu Hương for allowing me 
to do the study in FilaBavi and Hoankiem, and for help to set up the study there. I 
further thank Nguyễn Thị Kim Chúc for co-authorship.  
 
I would like to thank Đinh Thanh Điệp, Đỗ Thị Lịch, Tống Văn Minh, Đỗ Minh 
Thư, Trần Thị Mùi, Nguyễn Văn Đĩnh, Trần Bích Thủy, my research team, for 
helping me collecting the data but above all for your warm friendship. Thank you 
very much indeed for supporting me all the time. My thesis could not have been 
realised without your help.  
 
Thanks all fieldworkers, supervisors, chị Hải, em Long in FilaBavi, and all the 
staffs of the health care stations and freelancers in Hoankiem for helping me with 
the questionnaire survey as well as for inviting the study subjects to the health 
care stations to the clinical examinations.  
 
I would like to thank all past and present researchers and colleagues at the Unit of 
Lung and Allergy research. To Britt-Marie Sundblad for answering all my 
questions and for nice chats at work place. Thank you so much for your kind 
assistance. To Sven-Erik Dahlén, Ingrid Delin, Anna James, Roelinde Middelveld, 
Anna Hedelin, Jeong Hee Choi and Jesper Säfholm and all others for your 
friendship and encouragement.   
 
Many thanks to Karin Sahlander, for being a friend to me in so many meaningful 
ways. Thank you for all you’ve done. It was a great help in a most difficult time. 
Thanks to Åsa Andersson for teaching me the rules of Karolinska Institutet.  
  
Many thanks to Ulla Tunkara, Anna Merca Öberg, Yvonne Nygren, Catherine 
Bollö, Margareta Andersson for administrative help.  
 
Thank you all co-workers within the OLIN group in Luleå. To Sigrid Sundberg 
and Ann-Christin Jonsson for nice field work trips in northern Sweden, to Linnéa 
Hedman for friendship and helping me submitting papers and abstracts, and to 
Helena Backman for helping me with statistical programs.  
 
To my Vietnamese friends, Vũ Thanh Huyền, Hà Trần Hưng, Nguyễn Ngọc 
Dung, Nguyễn Việt Hà, Trần Thanh Hương, Vũ Hồng Thăng, Đỗ Duy Cường, Vũ 
Văn Tâm, Hoàng Thị Thu Hà, Nguyễn Thị Thu Hương, Nguyễn Văn Đô, Vương 
Tuyết Mai, Nguyễn Anh Tuấn, Phạm Hồng Thắng, Nguyễn Văn Tuấn thank you 
for sharing the nice time in Stockholm with me. Thanks so much to all involved in 
friends to friends. With you, I feel closer to Việt nam when I am in Sweden.  
 
I thank Nguyễn Thị Thu Hường, the secretary of the Sida/Sarec office at Hanoi 
Medical University, for all your administrative work and help in Việt nam.  
 
To my colleagues at the Allergology Department, Hanoi Medical University and 
the Allergy & Immunology Department, Bạch mai hospital in Hà nội, Việt nam, 
especially to Association Professor Nguyễn Văn Đoàn and Doctor Đỗ Trương 
Thanh Lan, thank you for your support all the time.  
 
 46 
I thank my brothers in law and my dear sisters for taking care of our Daddy when 
I was not at home. I thank my parents in law for taking care of my family and my 
children when I have been abroad.  
 
To my Daddy and my Mommy since long gone, I want to say thank you for 
growing up me in a loving environment. You always done for the best things and 
guided me on a right path. Thank you for accepting me exactly as I am. More than 
anything, I want you to know how much I love you.  
 
Last, but not least, many thanks to my family. My husband, Nguyễn Vũ Trung, 
thank for being such a great husband and father and making it so easy for me to 
stay in touch with the most loving side of myself. Thank you for taking care of 
our family when I was abroad for the PhD studies. Thank for your huge 
knowledge of IT and willingness to help me always when needed. Kiên and Phú, 
my lovely boys, thank you for showing up in my life and brightening it by funny 
things, sweet smiles and nice words. It was hard to live without Mom or Dad, I 
knew that. Many thanks to both of you for your understanding and patience with 
me. I love you so much. How great it would be to carry our love with us and 
maintain it powerfully forever. 
 
The study was mainly supported by grants from the Swedish governmental 
SIDA’s Secretariat for Research Cooperation for the bilateral cooperation between 
Vietnam and Sweden, as well as support from Karolinska International Research 
and Training Committee (KIRT). Additional funding was from the Swedish Heart 
Lung foundation and the Swedish Asthma & Allergy Foundation. 
GlaxoSmithKline in Việt nam gave Ventoline for the reversibility testing. I hereby 
thank for all contributions from institutions, funds and companies.  
 
 
   47 
 
REFERENCES 
 
 
 
AAAAI (2009). Allergy and asthma statistics. 
http://www.aaaai.org/media/statistics/. 
Abdulah, S. (1999). National Health Morbidity Survey: Healthrisk behavior 
among adolescents. Ministry of Health in Malaysia. 
Akdemir, C., & Yilmaz, S. (2009). Sensitization to house-dust mite and mite 
fauna in selected children's homes in Kutahya, Turkey. Turk J Pediatr, 51, 
232-237. 
Al-Naggar, R.A., Al-Dubai, S.A., Al-Naggar, T.H., Chen, R., & Al-Jashamy, K. 
(2011). Prevalence and of smoking and associated factors among 
Malaysian University students. Asian Pac J Cancer Prev, 12, 619-624. 
Almqvist, C., Pershagen, G., & Wickman, M. (2005). Low socioeconomic status 
as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth 
cohort. Clin Exp Allergy, 35, 612-618. 
Arruda, L.K., Vailes, L.D., Ferriani, V.P., Santos, A.B., Pomes, A., & Chapman, 
M.D. (2001). Cockroach allergens and asthma. J Allergy Clin Immunol, 
107, 419-428. 
Asher, M.I., Montefort, S., Bjorksten, B., Lai, C.K., Strachan, D.P., Weiland, 
S.K., et al. (2006). Worldwide time trends in the prevalence of symptoms 
of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC 
Phases One and Three repeat multicountry cross-sectional surveys. Lancet, 
368, 733-743. 
Au, D.H., Bryson, C.L., Chien, J.W., Sun, H., Udris, E.M., Evans, L.E., et al. 
(2009). The effects of smoking cessation on the risk of chronic obstructive 
pulmonary disease exacerbations. J Gen Intern Med, 24, 457-463. 
Bakken, H.N., Nafstad, P., Bolle, R., & Nystad, W. (2007). Skin sensitization in 
school children in northern and southern Norway. J Asthma, 44, 23-27. 
Baratawidjaja, I.R., Baratawidjaja, P.P., Darwis, A., Soo-Hwee, L., Fook-Tim, C., 
Bee-Wah, L., et al. (1999). Prevalence of allergic sensitization to regional 
inhalants among allergic patients in Jakarta, Indonesia. Asian Pac J 
Allergy Immunol, 17, 9-12. 
Basagana, X., Sunyer, J., Kogevinas, M., Zock, J.P., Duran-Tauleria, E., Jarvis, 
D., et al. (2004). Socioeconomic status and asthma prevalence in young 
adults: the European Community Respiratory Health Survey. Am J 
Epidemiol, 160, 178-188. 
Bauchau, V., & Durham, S.R. (2004). Prevalence and rate of diagnosis of allergic 
rhinitis in Europe. Eur Respir J, 24, 758-764. 
Biino, G., Rezzani, C., Grassi, M., & Marinoni, A. (2000). ECRHS screening 
questionnaire scoring: a methodological suggestion for asthma assessment. 
European Community Health Survey. J Outcome Meas, 4, 740-762. 
Bjerg, A., Hedman, L., Perzanowski, M.S., Platts-Mills, T., Lundback, B., & 
Ronmark, E. (2007). Family history of asthma and atopy: in-depth 
 48 
analyses of the impact on asthma and wheeze in 7- to 8-year-old children. 
Pediatrics, 120, 741-748. 
Bjornsson, E., Plaschke, P., Norrman, E., Janson, C., Lundback, B., Rosenhall, A., 
et al. (1994). Symptoms related to asthma and chronic bronchitis in three 
areas of Sweden. Eur Respir J, 7, 2146-2153. 
Bloomfield, S.F., Stanwell-Smith, R., Crevel, R.W., & Pickup, J. (2006). Too 
clean, or not too clean: the hygiene hypothesis and home hygiene. Clin 
Exp Allergy, 36, 402-425. 
Bouayad, Z., Aichane, A., Afif, A., Benouhoud, N., Trombati, N., Chan-Yeung, 
M., et al. (2006). Prevalence and trend of self-reported asthma and other 
allergic disease symptoms in Morocco: ISAAC phase I and III. Int J 
Tuberc Lung Dis, 10, 371-377. 
Bousquet, J., Burney, P.G., Zuberbier, T., Cauwenberge, P.V., Akdis, C.A., 
Bindslev-Jensen, C., et al. (2009). GA2LEN (Global Allergy and Asthma 
European Network) addresses the allergy and asthma 'epidemic'. Allergy, 
64, 969-977. 
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A., et 
al. (2008). Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 
update (in collaboration with the World Health Organization, GA(2)LEN 
and AllerGen). Allergy, 63 (Suppl 86), 8-160. 
Brannan, J.D. (2010). Bronchial hyperresponsiveness in the assessment of asthma 
control: Airway hyperresponsiveness in asthma: its measurement and 
clinical significance. Chest, 138, 11S-17S. 
Burney, P.G., Luczynska, C., Chinn, S., & Jarvis, D. (1994). The European 
Community Respiratory Health Survey. Eur Respir J, 7, 954-960. 
Busse, W.W. (2010). The relationship of airway hyperresponsiveness and airway 
inflammation: Airway hyperresponsiveness in asthma: its measurement 
and clinical significance. Chest, 138, 4S-10S. 
Celli, B.R., & MacNee, W. (2004). Standards for the diagnosis and treatment of 
patients with COPD: a summary of the ATS/ERS position paper. Eur 
Respir J, 23, 932-946. 
Chan-Yeung, M., Zhan, L.X., Tu, D.H., Li, B., He, G.X., Kauppinen, R., et al. 
(2002). The prevalence of asthma and asthma-like symptoms among adults 
in rural Beijing, China. Eur Respir J, 19, 853-858. 
Chew, F.T., Lim, S.H., Goh, D.Y., & Lee, B.W. (1999). Sensitization to local 
dust-mite fauna in Singapore. Allergy, 54, 1150-1159. 
Chuc, N.T., & Diwan, V. (2003). FilaBavi, a demographic surveillance site, an 
epidemiological field laboratory in Vietnam. Scand J Public Health Suppl, 
62, 3-7. 
Cingi, C., Cakli, H., Us, T., Akgun, Y., Kezban, M., Ozudogru, E., et al. (2005). 
The prevalence of allergic rhinitis in urban and rural areas of Eskisehir-
Turkey. Allergol Immunopathol (Madr), 33, 151-156. 
Cockcroft, D.W. (2010). Direct challenge tests: Airway hyperresponsiveness in 
asthma: its measurement and clinical significance. Chest, 138, 18S-24S. 
Cruz, A.A., Popov, T., Pawankar, R., Annesi-Maesano, I., Fokkens, W., Kemp, J., 
et al. (2007). Common characteristics of upper and lower airways in 
rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. 
Allergy, 62 Suppl 84, 1-41. 
Curotto de Lafaille, M.A., Lafaille, J.J., & Graca, L. (2010). Mechanisms of 
tolerance and allergic sensitization in the airways and the lungs. Curr Opin 
Immunol, 22, 616-622. 
   49 
Dejsomritrutai, W., Nana, A., Chierakul, N., Tscheikuna, J., Sompradeekul, S., 
Ruttanaumpawan, P., et al. (2006). Prevalence of bronchial 
hyperresponsiveness and asthma in the adult population in Thailand. 
Chest, 129, 602-609. 
Dreborg, S., Backman, A., Basomba, A., Bousquet, J., & Malling, D. (1989). Skin 
tests used in type 1 allergy testing. Position paper of European Academy 
of Allergology and Clinical Immunology Allergy, 44 (Suppl 10), 1-59. 
Ebert, C.S., Jr., & Pillsbury, H.C., 3rd (2011). Epidemiology of allergy. 
Otolaryngol Clin North Am, 44, 537-548, vii. 
ECRHS (1996). Variations in the prevalence of respiratory symptoms, self-
reported asthma attacks, and use of asthma medication in the European 
Community Respiratory Health Survey (ECRHS). Eur Respir J, 9, 687-
695. 
Eisner, M.D., Blanc, P.D., Omachi, T.A., Yelin, E.H., Sidney, S., Katz, P.P., et al. 
(2011). Socioeconomic status, race and COPD health outcomes. J 
Epidemiol Community Health, 65, 26-34. 
Ekerljung, L., Andersson, A., Sundblad, B.M., Ronmark, E., Larsson, K., 
Ahlstedt, S., et al. (2010a). Has the increase in the prevalence of asthma 
and respiratory symptoms reached a plateau in Stockholm, Sweden? Int J 
Tuberc Lung Dis, 14, 764-771. 
Ekerljung, L., Sundblad, B.M., Ronmark, E., Larsson, K., & Lundback, B. 
(2010b). Incidence and prevalence of adult asthma is associated with low 
socio-economic status. Clin Respir J, 4, 147-156. 
Eriksson, J., Ekerljung, L., Pullerits, T., Holmberg, K., Ronmark, E., Lotvall, J., et 
al. (2011). Prevalence of chronic nasal symptoms in West Sweden: risk 
factors and relation to self-reported allergic rhinitis and lower respiratory 
symptoms. Int Arch Allergy Immunol, 154, 155-163. 
Farfel, A., Tirosh, A., Derazne, E., Garty, B.Z., & Afek, A. (2010). Association 
between socioeconomic status and the prevalence of asthma. Ann Allergy 
Asthma Immunol, 104, 490-495. 
Fletcher, C., & Peto, R. (1977). The natural history of chronic airflow obstruction. 
Br Med J, 1, 1645-1648. 
Flohr, C., Tuyen, L.N., Lewis, S., Quinnell, R., Minh, T.T., Liem, H.T., et al. 
(2006). Poor sanitation and helminth infection protect against skin 
sensitization in Vietnamese children: A cross-sectional study. J Allergy 
Clin Immunol, 118, 1305-1311. 
Franzese, C.B., & Burkhalter, N.W. (2010). The patient with allergies. Med Clin 
North Am, 94, 891-902. 
Fukuchi, Y., Nishimura, M., Ichinose, M., Adachi, M., Nagai, A., Kuriyama, T., 
et al. (2004). COPD in Japan: the Nippon COPD Epidemiology study. 
Respirology, 9, 458-465. 
Fuller, T. (2007). Air pollution fast becoming an issue in booming Vietnam. The 
New York Times, July 6. 
Ghaffari, J., Khademloo, M., Saffar, M.J., Rafiei, A., & Masiha, F. (2010). 
Hypersensitivity to house dust mite and cockroach is the most common 
allergy in north of Iran. Iran J Immunol, 7, 234-239. 
Gilljam, H. (2007). Smoking cessation the most important causal treatment in 
COPD. Lakartidningen, 104 (13), 1047-1049. 
GINA (2010). Global initiative for asthma (GINA). Available from 
http://www.ginasthma.org 3. 
 50 
GOLD (2010). Global Initiative for chronic obstructive lung disease. Available 
from http://www.goldcopd.org, 7-12. 
Gunnbjornsdottir, M.I., Norback, D., Bjornsson, E., Soon, A., Jarvis, D., Jogi, R., 
et al. (2009). Indoor environment in three North European cities in 
relationship to atopy and respiratory symptoms. Clin Respir J, 3, 85-94. 
Hargreave, F.E., Dolovich, J., O'Byrne, P.M., Ramsdale, E.H., Daniel, E.E. 
(1986). The origin of airway hyperresponsiveness. J Allergy Clin 
Immunol, 78(5), 825-832. 
Hedlund, U., Ronmark, E., Eriksson, K., Lundback, B., & Jarvholm, B. (2008). 
Occupational exposure to dust, gases and fumes, a family history of 
asthma and impaired respiratory health. Scand J Work Environ Health, 34, 
381-386. 
Hu, G., Zhou, Y., Tian, J., Yao, W., Li, J., Li, B., et al. (2010). Risk of COPD 
from exposure to biomass smoke: a metaanalysis. Chest, 138, 20-31. 
Hulin, M., Caillaud, D., & Annesi-Maesano, I. (2010). Indoor air pollution and 
childhood asthma: variations between urban and rural areas. Indoor Air, 
20, 502-514.  
Idolor, L.F., TS, D.E.G., Francisco, N.A., Roa, C.C., Ayuyao, F.G., Tady, C.Z., et 
al. (2011). Burden of obstructive lung disease in a rural setting in the 
Philippines. Respirology, 16, 1111-1118. 
Janson, C., Chinn, S., Jarvis, D., & Burney, P. (1997). Physician-diagnosed 
asthma and drug utilization in the European Community Respiratory 
Health Survey. Eur Respir J, 10, 1795-1802. 
Jenkins, C.N., Dai, P.X., Ngoc, D.H., Kinh, H.V., Hoang, T.T., Bales, S., et al. 
(1997). Tobacco use in Vietnam. Prevalence, predictors, and the role of the 
transnational tobacco corporations. JAMA, 277, 1726-1731. 
Jensen-Jarolim, E., & Untersmayr, E. (2008). Gender-medicine aspects in 
allergology. Allergy, 63, 610-615. 
Jung-Choi, K.H., Khang, Y.H., & Cho, H.J. (2011). Hidden female smokers in 
Asia: a comparison of self-reported with cotinine-verified smoking 
prevalence rates in representative national data from an Asian population. 
Tob Control. 
Juusela, M., Poussa, T., Kotaniemi, J., Lundback, B., & Sovijarvi, A. (2008). 
Bronchial hyperresponsiveness in a population of north Finland with no 
previous diagnosis of asthma or chronic bronchitis assessed with histamine 
and methacholine tests. Int J Circumpolar Health, 67, 308-317. 
Karmaus, W., Dobai, A.L., Ogbuanu, I., Arshard, S.H., Matthews, S., & Ewart, S. 
(2008). Long-term effects of breastfeeding, maternal smoking during 
pregnancy, and recurrent lower respiratory tract infections on asthma in 
children. J Asthma, 45, 688-695. 
Kelly, F.J., & Fussell, J.C. (2011). Air pollution and airway disease. Clin Exp 
Allergy, 41, 1059-1071. 
Kim, H., & Bernstein, J.A. (2009). Air pollution and allergic disease. Curr Allergy 
Asthma Rep, 9, 128-133. 
Kim, S.J., Suk, M.H., Choi, H.M., Kimm, K.C., Jung, K.H., Lee, S.Y., et al. 
(2006). The local prevalence of COPD by post-bronchodilator GOLD 
criteria in Korea. Int J Tuberc Lung Dis, 10, 1393-1398. 
Kim, Y.K., Chang, Y.S., Lee, M.H., Hong, S.C., Bae, J.M., Jee, Y.K., et al. 
(2002). Role of environmental exposure to spider mites in the sensitization 
and the clinical manifestation of asthma and rhinitis in children and 
   51 
adolescents living in rural and urban areas. Clin Exp Allergy, 32, 1305-
1309. 
Klossek, J.M., Annesi-Maesano, I., Pribil, C., & Didier, A. (2009). [INSTANT: 
national survey of allergic rhinitis in a French adult population based-
sample]. Presse Med, 38, 1220-1229. 
Knox, R.B., Suphioglu, C., Taylor, P., Desai, R., Watson, H.C., Peng, J.L., et al. 
(1997). Major grass pollen allergen Lol p 1 binds to diesel exhaust 
particles: implications for asthma and air pollution. Clin Exp Allergy, 27, 
246-251. 
Kogevinas, M., Zock, J.P., Jarvis, D., Kromhout, H., Lillienberg, L., Plana, E., et 
al. (2007). Exposure to substances in the workplace and new-onset asthma: 
an international prospective population-based study (ECRHS-II). Lancet, 
370, 336-341. 
Kongpanichkul, A., Vichyanond, P., & Tuchinda, M. (1997). Allergen skin test 
reactivities among asthmatic Thai children. J Med Assoc Thai, 80, 69-75. 
Kotaniemi, J., Sovijarvi, A., & Lundback, B. (2005). Chronic obstructive 
pulmonary disease in Finland: prevalence and risk factors. COPD, 2, 331-
339. 
Kynyk, J.A., Mastronarde, J.G., & McCallister, J.W. (2011). Asthma, the sex 
difference. Curr Opin Pulm Med, 17, 6-11. 
Laszlo, G. (2006). Standardisation of lung function testing: helpful guidance from 
the ATS/ERS Task Force. Thorax, 61, 744-746. 
Lee, Y.L., Hwang, B.F., Lin, Y.C., & Guo, Y.L. (2007). Time trend of asthma 
prevalence among school children in Taiwan: ISAAC phase I and III 
surveys. Pediatr Allergy Immunol, 18, 188-195. 
Li, Q., Hsia, J., & Yang, G. (2011). Prevalence of smoking in China in 2010. N 
Engl J Med, 364, 2469-2470. 
Lin, Y.C., Su, H.J., Hsiue, T.R., Lee, C.H., Chen, C.W., & Guo, Y.L. (2002). 
Levels of house dust mite-specific IgE and cockroach-specific IgE and 
their association with lower pulmonary function in Taiwanese children. 
Chest, 121, 347-353. 
Lindberg, A., Bjerg, A., Ronmark, E., Larsson, L.G., & Lundback, B. (2006). 
Prevalence and underdiagnosis of COPD by disease severity and the 
attributable fraction of smoking Report from the Obstructive Lung Disease 
in Northern Sweden Studies. Respir Med, 100, 264-272. 
Lindberg, A., Jonsson, A.C., Ronmark, E., Lundgren, R., Larsson, L.G., & 
Lundback, B. (2005). Prevalence of chronic obstructive pulmonary disease 
according to BTS, ERS, GOLD and ATS criteria in relation to doctor's 
diagnosis, symptoms, age, gender, and smoking habits. Respiration, 72, 
471-479. 
Lindgren, A., Stroh, E., Nihlen, U., Montnemery, P., Axmon, A., & Jakobsson, K. 
(2009). Traffic exposure associated with allergic asthma and allergic 
rhinitis in adults. A cross-sectional study in southern Sweden. Int J Health 
Geogr, 8, 25. 
Lindstrom, M., Kotaniemi, J., Jonsson, E., & Lundback, B. (2001). Smoking, 
respiratory symptoms, and diseases : a comparative study between 
northern Sweden and northern Finland: report from the FinEsS study. 
Chest, 119, 852-861. 
Liu, S., Zhou, Y., Wang, X., Wang, D., Lu, J., Zheng, J., et al. (2007). Biomass 
fuels are the probable risk factor for chronic obstructive pulmonary disease 
in rural South China. Thorax, 62, 889-897. 
 52 
Liu, Z.G., Song, J.J., & Kong, X.L. (2010). A study on pollen allergens in China. 
Biomed Environ Sci, 23, 319-322. 
Lotvall, J., Ekerljung, L., Ronmark, E.P., Wennergren, G., Linden, A., Ronmark, 
E., et al. (2009). West Sweden Asthma Study: prevalence trends over the 
last 18 years argues no recent increase in asthma. Respir Res, 10, 94. (E-
pub: October 12) 
Lundback, B., Lindberg, A., Lindstrom, M., Ronmark, E., Jonsson, A.C., Jonsson, 
E., et al. (2003). Not 15 but 50% of smokers develop COPD?--Report 
from the Obstructive Lung Disease in Northern Sweden Studies. Respir 
Med, 97, 115-122. 
Lundback, B., Ronmark, E., Jonsson, E., Larsson, K., Sandstrom, T. (2001). 
Incidence of physician-diagnosed asthma in adults--a real incidence or a 
result of increased awareness? Report from The Obstructive Lung Disease 
in Northern Sweden Studies. Respir Med, 95 (8), 685-692. 
Lundback, B., Nystrom, L., Rosenhall, L., & Stjernberg, N. (1991). Obstructive 
lung disease in northern Sweden: respiratory symptoms assessed in a 
postal survey. Eur Respir J, 4, 257-266. 
Lundback, B., Stjernberg, N., Rosenhall, L., Lindstrom, M., Jonsson, E., & 
Andersson, S. (1993). Methacholine reactivity and asthma. Report from 
the Northern Sweden Obstructive Lung Disease Project. Allergy, 48, 117-
124. 
Mannino, D.M., & Buist, A.S. (2007). Global burden of COPD: risk factors, 
prevalence, and future trends. Lancet, 370, 765-773. 
Mannino, D.M., Gagnon, R.C., Petty, T.L., & Lydick, E. (2000). Obstructive lung 
disease and low lung function in adults in the United States: data from the 
National Health and Nutrition Examination Survey, 1988-1994. Arch 
Intern Med, 160, 1683-1689. 
Matsui, E.C., Wood, R.A., Rand, C., Kanchanaraksa, S., Swartz, L., Curtin-
Brosnan, J., et al. (2003). Cockroach allergen exposure and sensitization in 
suburban middle-class children with asthma. J Allergy Clin Immunol, 112, 
87-92. 
Mekrungrongwong, S., Nakamura, K., Kizuki, M., Morita, A., Somkotra, T., 
Seino, K., et al. (2011). Great inclination to smoke among younger adults 
coming from low-socioeconomic class in Thailand. Int Arch Med, 4, 29. 
Meren, M., Jannus-Pruljan, L., Loit, H.M., Polluste, J., Jonsson, E., Kiviloog, J., 
et al. (2001). Asthma, chronic bronchitis and respiratory symptoms among 
adults in Estonia according to a postal questionnaire. Respir Med, 95, 954-
964. 
Milenkovic, B., Mitic-Milikic, M., Rebic, P., Vukcevic, M., Dudvarski-Ilic, A., 
Nagorni-Obradovic, L., et al. (2011). Asthma and chronic bronchitis 
symptoms among adult population of Belgrade. Srp Arh Celok Lek, 139, 
149-154. 
Montnemery, P., Adelroth, E., Heuman, K., Johannisson, A., Johansson, S.A., 
Lindholm, L.H., et al. (1998). Prevalence of obstructive lung diseases and 
respiratory symptoms in southern Sweden. Respir Med, 92, 1337-1345. 
Nathan, R.A., Meltzer, E.O., Derebery, J., Campbell, U.B., Stang, P.E., Corrao, 
M.A., et al. (2008). The prevalence of nasal symptoms attributed to 
allergies in the United States: findings from the burden of rhinitis in an 
America survey. Allergy Asthma Proc, 29, 600-608. 
   53 
Ng, T.P. (1999). Adult asthma prevalence, morbidity and mortality and their 
relationships with environmental and medical care factors in Singapore. 
Asian Pac J Allergy Immunol, 17, 127-135. 
Nga, N.N., Chai, S.K., Bihn, T.T., Redding, G., Takaro, T., Checkoway, H., et al. 
(2003). ISAAC-based asthma and atopic symptoms among Ha Noi school 
children. Pediatr Allergy Immunol, 14, 272-279. 
Nicolaou, N., Siddique, N., & Custovic, A. (2005). Allergic disease in urban and 
rural populations: increasing prevalence with increasing urbanization. 
Allergy, 60, 1357-1360. 
Nimmagadda, S.R., & Evans, R., 3rd (1999). Allergy: etiology and epidemiology. 
Pediatr Rev, 20, 111-115; quiz 116. 
Norrman, E., Plaschke, P., Bjornsson, E., Rosenhall, L., Lundback, B., Jansson, 
C., et al. (1998). Prevalence of bronchial hyper-responsiveness in the 
southern, central and northern parts of Sweden. Respir Med, 92, 480-487. 
Ober, C., & Hoffjan, S. (2006). Asthma genetics 2006: the long and winding road 
to gene discovery. Genes Immun, 7, 95-100. 
Ober, C., & Yao, T.C. (2011). The genetics of asthma and allergic disease: a 21st 
century perspective. Immunol Rev, 242, 10-30. 
Pallasaho, P., Ronmark, E., Haahtela, T., Sovijarvi, A.R., & Lundback, B. (2006). 
Degree and clinical relevance of sensitization to common allergens among 
adults: a population study in Helsinki, Finland. Clin Exp Allergy, 36, 503-
509. 
Pallasaho, P., Lundback, B., Laspa, S.L., Jonsson, E., Kotaniemi, J., Jovijarvi, 
A.R., et al. (1999). Increasing prevalence of asthma but not of chronic 
bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir 
Med, 93 (11), 798-809.  
Paoletti, P., Carmignani, G., Viegi, G., Carrozzi, L., Bertieri, C., Di Pede, F., et al. 
(1989). Prevalence of asthma and asthma symptoms in a general 
population sample of north Italy. Eur Respir J Suppl, 6, 527s-531s. 
Park, H.S., Choi, G.S., Cho, J.S., & Kim, Y.Y. (2009). Epidemiology and current 
status of allergic rhinitis, asthma, and associated allergic diseases in 
Korea: ARIA Asia-Pacific workshop report. Asian Pac J Allergy Immunol, 
27, 167-171. 
Parnia, S., Brown, J.L., & Frew, A.J. (2002). The role of pollutants in allergic 
sensitization and the development of asthma. Allergy, 57, 1111-1117. 
Phan, T.P., Ngo, Q.C., & Duong, D.T. (2010). The study of the epidemiology of 
chronic obstructive pulmonary disease in suburban population of Hanoi 
city and Bacgiang province, Vietnam. ERS annual congress abstract, 
Barcelona, 2010. 
Platts-Mills, T.A., Erwin, E., Heymann, P., & Woodfolk, J. (2005). Is the hygiene 
hypothesis still a viable explanation for the increased prevalence of 
asthma? Allergy, 60 Suppl 79, 25-31. 
Polosa, R., Salvi, S., & Di Maria, G.U. (2002). Allergic susceptibility associated 
with diesel exhaust particle exposure: clear as mud. Arch Environ Health, 
57, 188-193. 
Prasarnphanich, T., & Sindhurat, S. (2005). Sensitization to common indoor 
allergens and its association with allergic diseases in Thai female high-
school students. Pediatr Allergy Immunol, 16, 402-407. 
Puccio, F.A., Lynch, N.R., Noya, O., Noda, A., Hagel, I., Lopez, E., et al. (2004). 
Importance of including Blomia tropicalis in the routine diagnosis of 
 54 
Venezuelan patients with persistent allergic symptoms. Allergy, 59, 753-
757. 
Quah, B.S., Wan-Pauzi, I., Ariffin, N., & Mazidah, A.R. (2005). Prevalence of 
asthma, eczema and allergic rhinitis: two surveys, 6 years apart, in Kota 
Bharu, Malaysia. Respirology, 10, 244-249. 
Raherison, C., & Girodet, P.O. (2009). Epidemiology of COPD. Eur Respir Rev, 
18, 213-221. 
Raukas-Kivioja, A., Raukas, E., Loit, H.M., Kiviloog, J., Ronmark, E., Larsson, 
K., et al. (2003). Allergic sensitization among adults in Tallinn, Estonia. 
Clin Exp Allergy, 33, 1342-1348. 
Ronmark, E., Bjerg, A., Perzanowski, M., Platts-Mills, T., & Lundback, B. 
(2009a). Major increase in allergic sensitization in schoolchildren from 
1996 to 2006 in northern Sweden. J Allergy Clin Immunol, 124, 357-363, 
363 e351-315. 
Ronmark, E., Lundback, B., Jonsson, E., Jonsson, A.C., Lindstrom, M., & 
Sandstrom, T. (1997). Incidence of asthma in adults--report from the 
Obstructive Lung Disease in Northern Sweden Study. Allergy, 52, 1071-
1078. 
Ronmark, E.P., Ekerljung, L., Lotvall, J., Toren, K., Ronmark, E., & Lundback, 
B. (2009b). Large scale questionnaire survey on respiratory health in 
Sweden: effects of late- and non-response. Respir Med, 103, 1807-1815. 
Saenghirunvattana, S., Kongngeon, V., Aeimrerksiri, B., Jerathamopart, P., 
Thamakumpee, K., Reechaipichitkul, W., et al. (2001). Chronic 
obstructive pulmonary diseases in Thailand: incidence, prevalence, present 
status and future trends. J Med Assoc Thai, 84, 1407-1411. 
Sakurai, Y., Nakamura, K., Teruya, K., Shimada, N., Umeda, T., Tanaka, H., et al. 
(1998). Prevalence and risk factors of allergic rhinitis and cedar pollinosis 
among Japanese men. Prev Med, 27, 617-622. 
Sam, C.K., Soon, S.C., Liam, C.K., Padmaja, K., & Cheng, H.M. (1998). An 
investigation of aeroallergens affecting urban Malaysian asthmatics. Asian 
Pac J Allergy Immunol, 16, 17-20. 
Samet, J.M. (1987). Epidemiologic approaches for the identification of asthma. 
Chest, 91, 74S-78S. 
Schirnhofer, L., Lamprecht, B., Vollmer, W.M., Allison, M.J., Studnicka, M., 
Jensen, R.L., et al. (2007). COPD prevalence in Salzburg, Austria: results 
from the Burden of Obstructive Lung Disease (BOLD) Study. Chest, 131, 
29-36. 
Seth, D., Secord, E., & Kamat, D. (2007). Allergic rhinitis. Clin Pediatr (Phila), 
46, 401-407. 
Sheffield, P.E., Weinberger, K.R., & Kinney, P.L. (2011). Climate change, 
aeroallergens, and pediatric allergic disease. Mt Sinai J Med, 78, 78-84. 
Simpson, C.R., & Sheikh, A. (2010). Trends in the epidemiology of asthma in 
England: a national study of 333,294 patients. J R Soc Med, 103, 98-106. 
Singh, P.N., Yel, D., Sin, S., Khieng, S., Lopez, J., Job, J., et al. (2009). Tobacco 
use among adults in Cambodia: evidence for a tobacco epidemic among 
women. Bull World Health Organ, 87, 905-912. 
Stang, P., Lydick, E., Silberman, C., Kempel, A., & Keating, E.T. (2000). The 
prevalence of COPD: using smoking rates to estimate disease frequency in 
the general population. Chest, 117, 354S-359S. 
Stempel, D.A., & Woolf, R. (2002). The cost of treating allergic rhinitis. Curr 
Allergy Asthma Rep, 2, 223-230. 
   55 
Stoller, J.K., & Aboussouan, L.S. (2005). Alpha1-antitrypsin deficiency. Lancet, 
365, 2225-2236. 
Strachan, D.P., Wong, H.J., & Spector, T.D. (2001). Concordance and 
interrelationship of atopic diseases and markers of allergic sensitization 
among adult female twins. J Allergy Clin Immunol, 108, 901-907. 
Sullivan, P.W., Ghushchyan, V.H., Slejko, J.F., Belozeroff, V., Globe, D.R., & 
Lin, S.L. (2011). The burden of adult asthma in the United States: 
evidence from the Medical Expenditure Panel Survey. J Allergy Clin 
Immunol, 127, 363-369. 
Sy, D.Q., Thanh Binh, M.H., Quoc, N.T., Hung, N.V., Quynh Nhu, D.T., Bao, 
N.Q., et al. (2007). Prevalence of asthma and asthma-like symptoms in 
Dalat Highlands, Vietnam. Singapore Med J, 48, 294-303. 
Takenaka, H., Zhang, K., Diaz-Sanchez, D., Tsien, A., & Saxon, A. (1995). 
Enhanced human IgE production results from exposure to the aromatic 
hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. 
J Allergy Clin Immunol, 95, 103-115. 
Tan, W.C., Seale, J.P., Charaoenratanakul, S., Guia, T.D., Ip, M., Mahayiddin, A., 
et al. (2003). COPD prevalence in 12 Asia-Pacific countries and regions: 
projections based on the COPD prevalence estimation model. Respirology, 
8, 192-198. 
Temprano, J., & Mannino, D.M. (2009). The effect of sex on asthma control from 
the National Asthma Survey. J Allergy Clin Immunol, 123, 854-860. 
Terada, N., Hamano, N., Maesako, K.I., Hiruma, K., Hohki, G., Suzuki, K., et al. 
(1999). Diesel exhaust particulates upregulate histamine receptor mRNA 
and increase histamine-induced IL-8 and GM-CSF production in nasal 
epithelial cells and endothelial cells. Clin Exp Allergy, 29, 52-59. 
Toren, K., Brisman, J., & Jarvholm, B. (1993). Asthma and asthma-like symptoms 
in adults assessed by questionnaires. A literature review. Chest, 104, 600-
608. 
Uthaisangsook, S. (2010). Risk factors for development of asthma in Thai adults 
in Phitsanulok: a university-based study. Asian Pac J Allergy Immunol, 28, 
23-28. 
van Beijsterveldt, C.E., & Boomsma, D.I. (2007). Genetics of parentally reported 
asthma, eczema and rhinitis in 5-yr-old twins. Eur Respir J, 29, 516-521. 
Vichyanond, P., Sunthornchart, S., Singhirannusorn, V., Ruangrat, S., 
Kaewsomboon, S., & Visitsunthorn, N. (2002). Prevalence of asthma, 
allergic rhinitis and eczema among university students in Bangkok. Respir 
Med, 96, 34-38. 
Viinanen, A., Munhbayarlah, S., Zevgee, T., Narantsetseg, L., Naidansuren, T., 
Koskenvuo, M., et al. (2005). Prevalence of asthma, allergic 
rhinoconjunctivitis and allergic sensitization in Mongolia. Allergy, 60, 
1370-1377. 
Vozoris, N.T., & Stanbrook, M.B. (2011). Smoking prevalence, behaviours, and 
cessation among individuals with COPD or asthma. Respir Med, 105, 477-
484. 
Warm, K., Backman, H., Lindberg, A., Lundback, B., & Ronmark, E. (2011). 
Low incidence and high remission of allergic sensitization among adults. J 
Allergy Clin Immunol. Oct 3, E-pub ahead of print.  
WHO (2009). WHO Report on the Global Tobacco Epidemic 2009: Implementing 
Smoke-Free Environments. Geneva, World Health Organization. 
 56 
Woolcock, A.J., Bastiampillai, S.A., Marks, G.B., & Keena, V.A. (2001). The 
burden of asthma in Australia. Med J Aust, 175, 141-145. 
Yin, P., Zhang, M., Li, Y., Jiang, Y., & Zhao, W. (2011). Prevalence of COPD 
and its association with socioeconomic status in China: findings from 
China Chronic Disease Risk Factor Surveillance 2007. BMC Public 
Health, 11, 586. 
Zhang, L., Han, D., Huang, D., Wu, Y., Dong, Z., Xu, G., et al. (2009). 
Prevalence of self-reported allergic rhinitis in eleven major cities in china. 
Int Arch Allergy Immunol, 149, 47-57. 
Zhang, W. (2007). Hypersensitivity diseases  Available from 
http://wenliang.myweb.uga.edu/mystudy/immunology/ScienceOfImmunolo
gy/Hypersensitivitydiseases.html. 
Zhong, N., Wang, C., Yao, W., Chen, P., Kang, J., Huang, S., et al. (2007). 
Prevalence of chronic obstructive pulmonary disease in China: a large, 
population-based survey. Am J Respir Crit Care Med, 176, 753-760. 
Zhong, N.S., Chen, R.C., O-Yang, M., Wu, J.Y., Fu, W.X., & Shi, L.J. (1990). 
Bronchial hyperresponsiveness in young students of southern China: 
relation to respiratory symptoms, diagnosed asthma, and risk factors. 
Thorax, 45, 860-865. 
Zilmer, M., Steen, N.P., Zachariassen, G., Duus, T., Kristiansen, B., & Halken, S. 
(2011). Prevalence of asthma and bronchial hyperreactivity in Danish 
schoolchildren: no change over 10 years. Acta Paediatr, 100, 385-389. 
 
 
   57 
APPENDIX 
 
 
Self-administrated questionnaire  
 
Answer be ticking a cross (x) in the bracelets or writing on appropriate line. 
Name:……………………………… Sex: M ( )  W ( )    Age……………………. 
Address:…………………………………………… Phone number:……………… 
ID:………………………………HHID………………….Cluster:……………….. 
 
              No/ 
                          Yes   don’t now   
       
1.   Have or have any of your parents, brothers or sisters had:        
      a)  Asthma   (  )  (  ) 
      b)  Allergic rhinitis (hay-fever) or allergic eye catarrh    (  )        (  ) 
      c)  Chronic bronchitis, COPD or emphysema    (  )  (  ) 
     
2.  Have you now or have you ever had any of the following 
diseases : 
    
      a)  Asthma  (  )  (  ) 
      b)  Allergic rhinitis (hay-fever) or allergic eye catarrh    (  )  (  ) 
      c)  Chronic bronchitis, COPD or emphysema    (  )  (  ) 
      d)  Any other lung- or airways disease  (  )  (  ) 
           If “yes”, which?..................................................................       
     
3.   Have you been diagnosed as having asthma by a doctor?  (  )  (  ) 
      If “yes”:      
a) How old were you when you got asthma?................years      
     
4.   Have you been diagnosed as having chronic bronchitis, 
COPD or emphysema by a doctor? 
  
(  ) 
  
(  ) 
     
5.  Do you currently use asthma medicines (permanently or as 
needed)?  
 (  )  (  ) 
     
6.   Have you now or have you had asthma symptoms during the 
last 10 years (intermittent breathlessness or attacks of shortness 
of breath, the symptoms may exist simultaneously with or 
without cough or wheezing)?  
If “yes”: 
  
 
(  ) 
  
 
(  ) 
      a)  Have you had these symptoms during the last year (last 12 
months)?  
 (  )  (  ) 
     
7.   Have you had longstanding cough during the last year?   (  )  (  ) 
     
8.   Do you usually have phlegm when coughing, or do you have 
phlegm in your chest, which is difficult to bring up?  
  
(  )     
  
(  ) 
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If “yes”: 
      a) Do you bring up phlegm on most days during periods of at 
least three months?   
 (  )  (  ) 
      b) Have you had such periods during at least two successive 
years? 
 (  )   (  ) 
     
9.   Do you usually have wheezing, whistling or a noisy sound in 
your chest when breathing? 
 (  )  (  ) 
     
10. Have you at any time during the last 12 months had 
wheezing or whistling in your chest? 
If “yes”: 
  
(  ) 
 
  
(  ) 
      a)  Have you been at all breathless when the wheezing or 
whistling was present? 
 (  )  (  ) 
      b)  Have you at any time had this wheezing or whistling 
when you did not have a cold? 
 (  )  (  ) 
     
11. Have you woken up with tightness in your chest at any time 
during the last 12 months?   
 (  )  (  ) 
     
12. Do you get short of breath when you walk with other people 
of your own age on level ground at normal pace?  
  
(  ) 
  
(  ) 
     
13. Do you usually have breathlessness, wheeze or severe cough:       
a) on effort  (  )  (  ) 
      b)   in cold weather  (  )  (  ) 
      c)   on effort in cold weather during winter    (  )  (  ) 
      d)   in dusty places  (  )  (  ) 
      e)   by cigarette or tobacco smoke   (  )  (  ) 
f) by car exhaust fumes  (  )  (  ) 
      g)   by strong smelling scents (parfumes, spices, printing ink, 
cleaner, smelling flowers)? 
 (  )  (  ) 
      h)   by pollen from grass and/or trees   (  )  (  ) 
       i)   at contact with furred animals (cat, dog, horse, pets or 
other furred animals)   
 (  )  (  ) 
     
14. Have you ever reacted with breathing difficulties within 3 
hours after taking a pain killer? 
 (  )  (  ) 
      If “yes”:     
      a) Do you remember the name of the tablet?...........................     
     
15. Do you have blocking of your nose more or less 
permanently? 
    
      Irrespectively of “yes” or “no”:  (  )  (  ) 
      a) Do you have rhinitis or a runny nose more or less 
permanently?  
 (  )  (  ) 
     
16. Do you smoke? (Smokers also include those who smoke a 
few cigarettes or pipe fills a week and those who have stopped  
smoking during the last 12 months) 
  
(  ) 
  
(  ) 
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      If “yes”:  
a) How many cigarettes do you smoke per day? 
Less than 5  (  )     5 – 14  (  )   15 – 24  (  )   25 or more  (  ) 
    
      If “no”:      
      b)   Have you been a smoker but have stopped smoking more 
than one year ago?  
 (  )  (  ) 
      If you are or have been a smoker:     
b) How old were you when you started to smoke?                           
……years 
    
     
17. What is or what has been your main work or occupation? 
      ....................... ...............................................................   
    
      a) How many years have you had this main work or 
occupation?    ......................years 
    
     
18. Have you now another work or occupation (other work / 
profession, or are you studying, unemployed, house-wife, retired, 
have sickness pension etc.)?  
      If “yes”:  
  
(  ) 
  
(  ) 
a) What work or occupation? .................................................                                                                         
b) Since how many years? ………….. years                                                        
     
19. Have you been heavily exposed to dust, gases or fumes at 
your work? 
 (  )  (  ) 
     
20. How many times a week (in average) do you eat fish?             
........................................  
    
     
21. How many times a week do you exercise or do sports so 
much that you sweat or get breathless, or go for long-walks, 
skiing or similar activities?   ..................... 
    
           
22. Did you live at country-side (not town or suburb) during your 
first years of life?   
 (  )  (  ) 
      a) Did your family live on a farm during your first years of 
life?  
 (  )  (  ) 
 
23. Do you have any ventilation fans in your house?                        
  
(  ) 
  
(  ) 
 
24. Is the kitchen separated from the living room and/or sleeping 
room in your house? 
  
(  ) 
  
(  ) 
 
25. What kind of oven/production do you use to heat the food? 
Coal ( )        Dung ( )          Wood ( )        Straw ( )              
Leaves ( )            Kerosene ( )            Electricity ( )         Gas ( ) 
    
     
 
                                            Thank you for your participation! 
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Questionnaire for the structured interview survey 
 
Name: ..........................................................Sex: M ( ) W ( )  
Date of birth: ….…/….…/………                                       
Adress:.......................................................................Phone number: …………….. 
ID:…….......................... HHID:…………………….Cluster:…………………..…  
Interviewer: ..................................................................... 
 
 
Answer be ticking a cross (x) in the bracelets or writing on appropriate line. 
 
                                                                                                                                No       Yes 
1. Have you had wheezing or whistling in your chest at any time in 
the last 12 months? 
 
(  )  (  ) 
if ‘yes’       
        1.1. Have you been at all breathless when the wheezing noise 
was present? 
 
(  )  (  ) 
        1.2. Have you had this wheezing or whistling when you did not 
have a cold? 
 
(  )  (  ) 
     
2. Do you usually have wheezing, whistling or a noisy sound in your 
chest when breathing? 
 
(  )  (  ) 
     
3. Have you woken up with a feeling of tightness in your chest at 
any time in the last 12 months? 
 
(  )  (  ) 
     
4. Have you been woken by an attack of shortness of breath at any 
time in the last 12 months? 
 
(  )  (  ) 
     
5. Have you had longstanding cough during the last year?  (  )  (  ) 
     
6. Do you usually cough in the morning?  (  )  (  ) 
     
7. Do you usually cough during other times of the day, or at night?  (  )  (  ) 
     
8. Have you been woken by an attack of coughing at any time in the 
last 12 months? 
 
(  )  (  ) 
     
9. Do you usually have phlegm when coughing, or do you have 
phlegm in your chest which is difficult to bring up? 
 
(  )  (  ) 
     
10. Do you bring up phlegm from your chest on most days for as 
much as three months each year?  
If yes, 
 
(  )  (  ) 
        10.1. For how many years? Year………….     
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11. Do you currently take asthma medicines or medicines for any 
airway or lung disease (permanently or as needed)? 
 
 
(  ) 
 
 
(  ) 
     
12. Has a doctor ever told you that you have chronic bronchitis or 
emphysema or COPD? 
  
(  ) 
 
 
(  ) 
     
13. Have you ever had asthma?  (  )  (  ) 
     
14. Have you been diagnosed as having asthma by a doctor?   (  )  (  ) 
If 'yes’ to any question 13 or 14       
        14.1 How old were you when you had your first attack of 
asthma? 
(If unsure, give your best guess!) Year:……………………. 
 
   
        14.2 Have you ever been hospitalised for asthma?  (  )  (  ) 
        14.3 Have you had an attack of asthma in the last 12 months?  (  )  (  ) 
        14.4. Are you currently taking any medicine (including 
inhalers, aerosols or tables) for asthma? 
 
(  )  (  ) 
     
15. Have you ever had TBC?  (  )  (  ) 
     
16. Do you currently have or have you ever had any lung or airway 
disease except asthma, chronic bronchitis, emphysema or COPD, or 
TBC?                          
 
(  )  (  ) 
If ‘yes’       
        16.1. What disease?...................................................................                                      
     
17. Do you get short of breath when you hurry on level ground                                                               
or when you walk in you own pace up a stair or a small slope? 
 
(  )  (  ) 
If ‘yes’       
        17.1. Do you get short of breath when you walk with other 
people of your own age on level ground at normal pace? 
 
(  )  (  ) 
     
18. Do you have any nasal allergies including hay fever?  (  )  (  ) 
If ‘yes’      
         18.1 Have you been troubled by nasal allergies in the last 12 
months? 
 
(  )  (  ) 
         18.2 Have you ever been troubled by nasal allergies for more 
than 4 days in any one week? 
 
(  )  (  ) 
         18.3 If yes did this happen for more than 4 weeks 
continuously? 
 
(  )  (  ) 
     
19. Has your nose been blocked for more than 12 weeks during the 
last 12 months? 
 
(  )  (  ) 
     
20. Have you had pain or pressure around the forehead, nose or eyes 
for more than 12 weeks during the last 12 months? 
 
(  )  (  ) 
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21. Have you had discoloured nasal discharge (snot) or discoloured 
mucus in the throat for more than 12 weeks during the last 12 
months? 
 
(  ) 
 
(  ) 
     
22. Has your sense of smell been reduced or absent for more than 12 
weeks during the last 12 months? 
 
(  )  (  ) 
     
23. Has a doctor ever told you that you have chronic sinusitis?  (  )  (  ) 
     
24. Have you ever had an itchy rash that was coming and going for 
at least 6 months? 
 
(  )  (  ) 
 
If ‘yes’   
 
   
       24.1 Have you had this itchy rash in the last 12 months?  (  )  (  ) 
       24.2 Does this affect only your hands?  (  )  (  ) 
     
25. Have you ever had eczema or any kind of skin allergy?    (  )  (  ) 
     
26. Have you ever smoked for as long as a year (means at least one 
cigarette per day or one cigar per week for one year)? 
 
(  )  (  ) 
If ‘yes’      
      26.1 How old were you when you started smoking?  (  )  (  ) 
      26.2 Have you smoked at all in the last month?  (  )  (  ) 
      26.3. Have you smoked at all in the last 12 months  (  )  (  ) 
If 'yes'      
                 26.3.1 How old were you when you stopped smoking?  
                            Years………….. 
 
   
      26.4 On average how much do you (or did you) smoke? 
Cigarettes per day ……… 
 
   
     
27. Does any member of your family smoke?  (  )  (  ) 
If ‘yes’      
       27.1. How many? Number: ………..     
       27.2. How many of them smoke inside the house? Number…….     
     
28. Are you currently (Tick one box only)     
a. Employed                                            ( )  (  )   
b. Self-employed                                     ( )     
c. Unemployed                                        ( )     
d. Not working because of poor health   ( )     
e. Full-time house person                       ( )     
f. Full-time student                                 ( )     
g. Retired                                                 ( )     
h. Other                                                    ( )     
     
 
29. What is your current work?...................................................... 
 
   
If ‘yes’          
    29.1. How many years have you worked at this occupation?  
Years:………………………………  
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30. Have you been worked in another occupation or in another field 
more than five years? 
 
(  )  (  ) 
If ‘yes’          
        30.1. In what work/occupation?.............................................     
        30.2. How many years did you work at this occupation? 
                                                   Years:…………….. 
 
   
     
31. Do you currently have or have you ever had any heart problems 
or heart disease?  
No    ( )                                                   Cardiac   ( ) 
Angina  ( )                                              Heart dysrhythmia ( ) 
Coronary artery surgery    ( )                 Other heart disease ( ) 
Balloon dilatation(Angioplasty)  ( ) 
 
 
   
     
32. Do you currently use any heart medication, including low dose 
ASA for preventing thrombosis? 
 
(  )  (  ) 
     
33. Do you currently have or have you ever had hypertension?  (  )  (  ) 
     
34. Do you currently use any medication against hypertension?  (  )  (  ) 
     
35. Do you currently have or have you ever had diabetes?  (  )  (  ) 
     
36. Do you currently have or have you ever had a rheumatic 
disease? 
 
(  )  (  ) 
 
37. Height: ……………cm 
      Weight…………….kg 
      Blood pressure…………………mm Hg 
38. What is today’s date…………../……./…….. 
 
 
Signature of interviewer 
 
